WEBVTT - Ep 218 The Lowdown on Statins

0:00:00.160 --> 0:00:03.320
<v Speaker 1>I was born into a rural farming family in northern Japan,

0:00:03.720 --> 0:00:06.760
<v Speaker 1>where I lived for seventeen years with my extended family,

0:00:07.000 --> 0:00:11.760
<v Speaker 1>including grandparents, parents, three brothers, and two sisters. My grandfather,

0:00:11.840 --> 0:00:14.480
<v Speaker 1>who had an interest in medicine and science, was a

0:00:14.520 --> 0:00:17.759
<v Speaker 1>great home teacher to me thanks to his influence. At

0:00:17.800 --> 0:00:20.680
<v Speaker 1>the age of eight, I dreamt of becoming a scientist.

0:00:21.200 --> 0:00:23.960
<v Speaker 1>After finishing high school in Akida, I entered to Hoku

0:00:24.079 --> 0:00:28.000
<v Speaker 1>University's College of Agriculture in Sendai in nineteen fifty three.

0:00:28.440 --> 0:00:31.160
<v Speaker 1>As a student, I was deeply impressed by the knowledge

0:00:31.160 --> 0:00:34.519
<v Speaker 1>that antibiotics had saved the lives of many patients with

0:00:34.560 --> 0:00:39.480
<v Speaker 1>infectious diseases. I received a PhD degree from Tohoku University

0:00:39.560 --> 0:00:43.239
<v Speaker 1>in nineteen sixty six. At this point, I became interested

0:00:43.360 --> 0:00:48.360
<v Speaker 1>in cholesterol biosynthesis. I eventually studied from September nineteen sixty

0:00:48.400 --> 0:00:51.720
<v Speaker 1>six to August nineteen sixty eight at the Albert Einstein

0:00:51.800 --> 0:00:55.480
<v Speaker 1>College of Medicine in New York. At that time, coronary

0:00:55.480 --> 0:00:57.800
<v Speaker 1>heart disease was the main cause of death in the

0:00:57.880 --> 0:01:02.360
<v Speaker 1>United States. The number of people with hypercholesterolemia, a precursor

0:01:02.400 --> 0:01:05.920
<v Speaker 1>to coronary heart disease, was said to exceed ten million.

0:01:06.560 --> 0:01:09.560
<v Speaker 1>My experience of living in New York made me realize

0:01:09.600 --> 0:01:13.760
<v Speaker 1>the importance of developing a cholesterol lowering drug. After coming

0:01:13.800 --> 0:01:17.520
<v Speaker 1>back to Tokyo in nineteen sixty eight, Sankyo Research Laboratories

0:01:17.560 --> 0:01:20.200
<v Speaker 1>gave me an opportunity to work on a project of

0:01:20.200 --> 0:01:24.240
<v Speaker 1>my own. Choosing I speculated that fungi like molds and

0:01:24.319 --> 0:01:31.040
<v Speaker 1>mushrooms would produce antibiotics that inhibited hmg CoA reductase compactin

0:01:31.520 --> 0:02:09.120
<v Speaker 1>seemed to be a wonderful gift from nature.

0:02:19.760 --> 0:02:24.560
<v Speaker 2>I want to know everything more that you're about to

0:02:24.600 --> 0:02:27.480
<v Speaker 2>tell me. You from that story, you will, you will.

0:02:27.600 --> 0:02:32.360
<v Speaker 1>So that was excerpted from actually two different articles written

0:02:32.560 --> 0:02:36.880
<v Speaker 1>by Akira Endo, who was the father of statins. He

0:02:37.840 --> 0:02:41.760
<v Speaker 1>discovered the first statn and he has written about this

0:02:41.800 --> 0:02:44.560
<v Speaker 1>in multiple different places. But this was from two papers,

0:02:44.600 --> 0:02:47.119
<v Speaker 1>one from two thousand and eight and one from twenty ten,

0:02:47.280 --> 0:02:50.119
<v Speaker 1>and we'll have them in our show notes. But yeah,

0:02:50.160 --> 0:02:54.320
<v Speaker 1>I loved, I love, just like I'm still amazed at

0:02:54.440 --> 0:02:57.359
<v Speaker 1>the logic link leap that it is.

0:02:57.520 --> 0:02:59.160
<v Speaker 2>That's what I that's what I want. I want so

0:02:59.240 --> 0:03:01.280
<v Speaker 2>much more of that. Like what was he thinking and

0:03:01.320 --> 0:03:04.520
<v Speaker 2>how did he piece these things together? And like I

0:03:04.560 --> 0:03:06.440
<v Speaker 2>want to know it all because I'm really, I'm really,

0:03:06.880 --> 0:03:10.799
<v Speaker 2>I'm really excited for this episode. Erin, should we.

0:03:10.280 --> 0:03:13.959
<v Speaker 3>Yeah, me too, Me too, It's going to be great. Hi.

0:03:14.240 --> 0:03:17.200
<v Speaker 2>I'm Aaron Welsh and I'm Erin allman Updyke.

0:03:16.919 --> 0:03:18.920
<v Speaker 3>And this is this podcast will kill you.

0:03:19.280 --> 0:03:23.800
<v Speaker 2>Welcome to Cholesterol Part two, Part two where we love in.

0:03:23.720 --> 0:03:30.120
<v Speaker 3>Blue Blue Yes, good ones. Yeah, yeah to this.

0:03:30.280 --> 0:03:32.600
<v Speaker 1>So if you didn't listen to last week's episode, you

0:03:32.680 --> 0:03:35.840
<v Speaker 1>really should because it'll give you some great foundation for

0:03:36.000 --> 0:03:39.280
<v Speaker 1>understanding why cholesterol does what it does in our bodies

0:03:39.320 --> 0:03:44.680
<v Speaker 1>and why certain levels of different types of cholesterol mean disease.

0:03:45.600 --> 0:03:48.960
<v Speaker 2>I know that we're biased, but I think it's a

0:03:48.960 --> 0:03:53.280
<v Speaker 2>great episode. You haven't listened to it, check it out.

0:03:53.360 --> 0:03:55.680
<v Speaker 2>And then today we're going to build on so much

0:03:55.680 --> 0:03:59.200
<v Speaker 2>of that and talk about how we deal with high

0:03:59.240 --> 0:04:01.120
<v Speaker 2>cholesterol and how we figured out how to deal with it,

0:04:01.200 --> 0:04:04.440
<v Speaker 2>and it's going to be really great. Yes, But before

0:04:04.440 --> 0:04:06.840
<v Speaker 2>we can start, it's quarantine time.

0:04:07.160 --> 0:04:11.280
<v Speaker 1>It is once again we are drinking plack attack.

0:04:13.480 --> 0:04:13.760
<v Speaker 3>Again.

0:04:13.880 --> 0:04:16.120
<v Speaker 1>Are we attacking plaque? Is plac attacking us?

0:04:16.200 --> 0:04:20.320
<v Speaker 2>A little bit of both? Yes, with black clack attack.

0:04:20.680 --> 0:04:24.000
<v Speaker 1>It's a pretty it's a pretty delicious, straightforward, nothing to

0:04:24.080 --> 0:04:29.400
<v Speaker 1>do with cholesterol, just delicious. It's blueberries smashed with lemon

0:04:29.480 --> 0:04:34.080
<v Speaker 1>juice and uh club soda and simple syrup.

0:04:34.320 --> 0:04:35.080
<v Speaker 2>And it meant.

0:04:37.720 --> 0:04:40.720
<v Speaker 1>I haven't putten down and yet it's like not, I

0:04:40.760 --> 0:04:41.640
<v Speaker 1>just didn't pull it up.

0:04:41.680 --> 0:04:44.240
<v Speaker 2>So we'll post the full recipe on our website, this

0:04:44.240 --> 0:04:46.880
<v Speaker 2>podcast with Killy dot com on our social media's which

0:04:46.920 --> 0:04:54.000
<v Speaker 2>include Instagram and blue Sky and Facebook, Facebook and TikTok.

0:04:54.160 --> 0:04:56.760
<v Speaker 2>I don't know if it's there on TikTok though, listen,

0:04:57.000 --> 0:04:58.560
<v Speaker 2>just follow us there.

0:04:59.040 --> 0:05:01.600
<v Speaker 3>You'll see what we're up to here, Absolutely you will.

0:05:01.880 --> 0:05:05.680
<v Speaker 1>Yeah, you can also see a little bit of what

0:05:05.680 --> 0:05:07.680
<v Speaker 1>we're up to by going to our website.

0:05:07.960 --> 0:05:10.320
<v Speaker 3>This podcast will kill You dot com. It's got yeah,

0:05:10.360 --> 0:05:11.960
<v Speaker 3>not not quite, but like it's got.

0:05:12.000 --> 0:05:15.280
<v Speaker 1>It's got resources, right, got lots. We've got all of

0:05:15.320 --> 0:05:18.400
<v Speaker 1>the papers we use for all of our episodes. It's

0:05:18.440 --> 0:05:22.680
<v Speaker 1>got links to our bookshop dot org, affiliate page, music

0:05:22.680 --> 0:05:28.040
<v Speaker 1>by Bloodmobile, links to merch links to Patreon, it's got

0:05:28.080 --> 0:05:31.280
<v Speaker 1>a first hand account, form of contact us form things

0:05:31.600 --> 0:05:33.640
<v Speaker 1>that everything explore.

0:05:33.480 --> 0:05:35.599
<v Speaker 2>Everything we could think of is there.

0:05:36.400 --> 0:05:37.120
<v Speaker 3>Yeah.

0:05:37.160 --> 0:05:40.000
<v Speaker 2>Thank you to everyone who has rated and reviewed and

0:05:40.040 --> 0:05:44.800
<v Speaker 2>subscribed on your podcatcher or YouTube of choice.

0:05:45.240 --> 0:05:48.359
<v Speaker 3>Yes, yes, we appreciate it. We do. I know, we know.

0:05:48.440 --> 0:05:50.719
<v Speaker 1>There are so much media out there that you can consume,

0:05:50.880 --> 0:05:54.240
<v Speaker 1>and so it means truly, it means so much to us.

0:05:54.320 --> 0:05:57.000
<v Speaker 1>It feels surreal that you're choosing to spend any time

0:05:57.040 --> 0:05:57.440
<v Speaker 1>with us.

0:05:57.640 --> 0:05:59.680
<v Speaker 2>I don't know. Every time and says they listen, I'm

0:05:59.720 --> 0:06:05.000
<v Speaker 2>like to me to us, what really, Yeah, it's incredible,

0:06:05.760 --> 0:06:09.520
<v Speaker 2>thank you, thank you. Okay, Aaron, tell me about this

0:06:09.560 --> 0:06:11.599
<v Speaker 2>guy and how he came up with statins and everything else.

0:06:11.640 --> 0:06:15.040
<v Speaker 1>Okay, absolutely, let's take a quick break and we'll do

0:06:15.080 --> 0:06:15.560
<v Speaker 1>all of that.

0:06:34.560 --> 0:06:36.200
<v Speaker 3>Last week I took us.

0:06:36.080 --> 0:06:38.800
<v Speaker 1>Through the story of cholesterol and how it earned its

0:06:38.800 --> 0:06:43.080
<v Speaker 1>reputation as a major cause of cardiovascular disease. Over the

0:06:43.120 --> 0:06:46.440
<v Speaker 1>course of about seven decades, from the nineteen tens to

0:06:46.560 --> 0:06:50.279
<v Speaker 1>the early nineteen eighties, researchers put the pieces of the

0:06:50.360 --> 0:06:54.159
<v Speaker 1>cholesterol puzzle together using a wide range of studies. We

0:06:54.240 --> 0:06:58.920
<v Speaker 1>had experimental ones like A. Nich Coow's athrosclerotic rabbits. There

0:06:59.040 --> 0:07:04.799
<v Speaker 1>were analytical epidemiological ones like the Framingham Heart study, genetic ones,

0:07:04.839 --> 0:07:08.720
<v Speaker 1>and mechanistic ones like Brown and Goldstein's Nobel Prize winning

0:07:08.800 --> 0:07:14.240
<v Speaker 1>work characterizing the LDL receptor, lots of different studies.

0:07:14.480 --> 0:07:16.120
<v Speaker 3>Different lines of evidence.

0:07:16.240 --> 0:07:20.800
<v Speaker 1>Yes, yes, And this week I'm going to pick up

0:07:20.880 --> 0:07:24.480
<v Speaker 1>with the final piece of this puzzle, cholesterol lowering drugs

0:07:24.520 --> 0:07:27.680
<v Speaker 1>and some of the controversy that surrounds them.

0:07:27.960 --> 0:07:29.360
<v Speaker 3>By the nineteen seventies, much of.

0:07:29.360 --> 0:07:34.160
<v Speaker 1>The cardiology world, like researchers, physicians, and institutes, they saw

0:07:34.200 --> 0:07:38.240
<v Speaker 1>the link between cholesterol and cardiovascular disease as a done deal.

0:07:38.560 --> 0:07:42.800
<v Speaker 1>This is established, Okay, now let's proceed from here. But

0:07:42.960 --> 0:07:47.560
<v Speaker 1>that knowledge didn't reach beyond that realm of experts, and

0:07:47.720 --> 0:07:53.120
<v Speaker 1>many physicians remained either skeptical or oblivious to this new knowledge. So,

0:07:53.200 --> 0:07:57.600
<v Speaker 1>for example, a nineteen eighty three study of internists in

0:07:57.600 --> 0:08:02.600
<v Speaker 1>the US showed that fifty percent did not recommend any therapy,

0:08:02.680 --> 0:08:08.160
<v Speaker 1>including diet, for cholesterol lowering unless levels were over three hundred.

0:08:08.880 --> 0:08:11.360
<v Speaker 2>Fast total in like the mid eighties.

0:08:11.400 --> 0:08:12.560
<v Speaker 3>Based nineteen eighty three.

0:08:12.680 --> 0:08:17.360
<v Speaker 1>Yeah, wow, yeah, it just it also shows how quickly

0:08:17.640 --> 0:08:18.560
<v Speaker 1>things have shifted.

0:08:19.120 --> 0:08:22.840
<v Speaker 2>Yeah, which is so interesting also because I just think about,

0:08:22.880 --> 0:08:26.920
<v Speaker 2>like we've talked about before, how slow changes in medicine,

0:08:26.960 --> 0:08:30.800
<v Speaker 2>and like, there are plenty of people practicing today who

0:08:30.840 --> 0:08:33.040
<v Speaker 2>were probably practicing in the eighties, like getting trained in

0:08:33.040 --> 0:08:35.800
<v Speaker 2>the eighties, so that it's just so interesting.

0:08:36.040 --> 0:08:37.160
<v Speaker 3>Yeah, yeah, it is.

0:08:37.240 --> 0:08:40.240
<v Speaker 1>It is really interesting, and I think it also like,

0:08:41.200 --> 0:08:44.640
<v Speaker 1>okay for you today this I wanted to share more

0:08:44.679 --> 0:08:46.440
<v Speaker 1>of these numbers because I think it'll come as a

0:08:46.440 --> 0:08:48.520
<v Speaker 1>real like double take.

0:08:48.840 --> 0:08:49.640
<v Speaker 3>Yeah, exactly.

0:08:50.280 --> 0:08:50.360
<v Speaker 2>So.

0:08:51.280 --> 0:08:53.840
<v Speaker 1>Of that of those fifty percent who wouldn't recommend any

0:08:53.840 --> 0:08:58.560
<v Speaker 1>therapy unless over three hundred hundred, nearly half said no

0:08:58.760 --> 0:09:02.880
<v Speaker 1>therapy unless levels or over three point forty three, and

0:09:02.960 --> 0:09:06.000
<v Speaker 1>twenty seven percent of those said that they would never

0:09:06.080 --> 0:09:10.000
<v Speaker 1>recommend drug treatment under any circumstances for cholesterol.

0:09:10.040 --> 0:09:10.720
<v Speaker 3>For cholesterol.

0:09:12.600 --> 0:09:18.120
<v Speaker 1>Yeah, So what would it take for high blood cholesterol

0:09:18.200 --> 0:09:21.840
<v Speaker 1>to be seen as a pressing public health issue, at

0:09:21.920 --> 0:09:25.920
<v Speaker 1>least among all medical professionals, if not the general public. Yeah,

0:09:26.360 --> 0:09:32.440
<v Speaker 1>an available treatment and evidence that intervention worked. Those two

0:09:32.559 --> 0:09:35.520
<v Speaker 1>things would emerge at nearly the same time in the

0:09:35.559 --> 0:09:36.640
<v Speaker 1>early nineteen eighties.

0:09:37.080 --> 0:09:39.280
<v Speaker 2>Arin. I don't want to interrupt you because I'm loving this.

0:09:39.360 --> 0:09:41.600
<v Speaker 2>But as a side note, you know what we should

0:09:41.640 --> 0:09:45.480
<v Speaker 2>do an episode on tell Me evidence based medicine.

0:09:45.640 --> 0:09:47.199
<v Speaker 3>Yeah, okay, because.

0:09:46.880 --> 0:09:48.360
<v Speaker 2>That is a really new thing.

0:09:50.600 --> 0:09:52.000
<v Speaker 3>Wait wait, wait, what do you mean by that is

0:09:52.040 --> 0:09:52.840
<v Speaker 3>a really new thing?

0:09:53.200 --> 0:09:56.599
<v Speaker 2>I mean The idea that we should only make recommendations

0:09:56.600 --> 0:10:00.000
<v Speaker 2>for things if we have evidence to support them is

0:10:00.120 --> 0:10:03.280
<v Speaker 2>a relatively new concept in the history of medicine, and

0:10:03.320 --> 0:10:03.680
<v Speaker 2>I mean.

0:10:03.760 --> 0:10:06.600
<v Speaker 1>Really humoral theory has tons of support.

0:10:06.720 --> 0:10:11.160
<v Speaker 2>Erin, sorry to cite.

0:10:11.280 --> 0:10:13.480
<v Speaker 1>No, we should definitely do We should definitely do that.

0:10:13.760 --> 0:10:16.560
<v Speaker 1>We've had ideas to do things like randomized control trials

0:10:16.559 --> 0:10:17.080
<v Speaker 1>as well.

0:10:17.200 --> 0:10:20.640
<v Speaker 2>Yes, and I know, just like, yeah, there's too long

0:10:20.679 --> 0:10:21.120
<v Speaker 2>of a list.

0:10:21.400 --> 0:10:23.880
<v Speaker 3>We have such a long list. It's great. It's a

0:10:23.960 --> 0:10:24.679
<v Speaker 3>good problem to have.

0:10:24.800 --> 0:10:26.360
<v Speaker 2>Okay, we're in the eighties.

0:10:26.480 --> 0:10:27.240
<v Speaker 3>We're in the eighties.

0:10:27.320 --> 0:10:29.640
<v Speaker 4>A lot of people are like, no, dude, give me

0:10:29.679 --> 0:10:33.439
<v Speaker 4>some evidence, right, And the cardiologists or the cardio cardiology

0:10:33.559 --> 0:10:37.400
<v Speaker 4>research people are like, oh my god, this we're in trouble.

0:10:37.480 --> 0:10:38.080
<v Speaker 2>We're in trouble.

0:10:38.440 --> 0:10:44.160
<v Speaker 1>Okay, So we needed treatment and proof that any sort

0:10:44.200 --> 0:10:46.120
<v Speaker 1>of intervention worked, whether it was the treatment or just

0:10:46.240 --> 0:10:50.840
<v Speaker 1>lowering cholesterol that that led to actual results. Those two things,

0:10:50.880 --> 0:10:54.520
<v Speaker 1>a treatment and proof of intervention, would emerge at nearly

0:10:54.600 --> 0:10:55.319
<v Speaker 1>the same.

0:10:55.120 --> 0:10:56.680
<v Speaker 3>Time in the early nineteen eighties.

0:10:56.840 --> 0:11:00.480
<v Speaker 1>Okay, so at the National Institutes of Health PLIANS had

0:11:00.480 --> 0:11:03.920
<v Speaker 1>been underway since nineteen seventy for a large scale study

0:11:03.960 --> 0:11:06.920
<v Speaker 1>that would measure the impact of cholesterol lowering drugs on

0:11:07.000 --> 0:11:11.840
<v Speaker 1>cardiovascular disease. Previous studies had shown that high blood cholesterol

0:11:11.920 --> 0:11:15.920
<v Speaker 1>levels overall correlated to higher rates of heart attacks, but

0:11:16.000 --> 0:11:19.560
<v Speaker 1>the next step was showing that lowering those levels would

0:11:19.559 --> 0:11:21.800
<v Speaker 1>then lead to fewer cardiac events.

0:11:21.960 --> 0:11:25.400
<v Speaker 2>Exactly, we know that there's this positive correlation between high

0:11:25.480 --> 0:11:28.520
<v Speaker 2>levels and bad outcomes. Can we change that?

0:11:28.840 --> 0:11:31.080
<v Speaker 3>Can we change that? Can we do something?

0:11:31.080 --> 0:11:33.360
<v Speaker 1>Because then that would also suggest it would be a

0:11:33.600 --> 0:11:35.679
<v Speaker 1>very great evidence for causation.

0:11:35.320 --> 0:11:37.800
<v Speaker 2>For causation, exactly, Yeah.

0:11:37.160 --> 0:11:40.560
<v Speaker 1>So the Coronary Primary Prevention trial was designed to do

0:11:40.679 --> 0:11:44.679
<v Speaker 1>exactly that show this line of causation. The study enrolled

0:11:45.120 --> 0:11:48.760
<v Speaker 1>three eight hundred men aged thirty five to fifty nine

0:11:48.880 --> 0:11:52.640
<v Speaker 1>with high total blood cholesterol so two sixty five or higher,

0:11:53.400 --> 0:11:56.600
<v Speaker 1>and they were to be followed for at least five years.

0:11:57.120 --> 0:12:00.000
<v Speaker 1>The treatment group was supposed to take a cholesterol lowering drug,

0:12:00.000 --> 0:12:04.400
<v Speaker 1>a cholestyramine. Statins weren't yet approved at this point, and

0:12:04.600 --> 0:12:08.960
<v Speaker 1>all participants were instructed to follow a cholesterol lowering diet. Okay,

0:12:09.320 --> 0:12:12.440
<v Speaker 1>knowing what we know today about the link between cholesterol

0:12:12.520 --> 0:12:15.280
<v Speaker 1>and cardiovascular disease, a trial like this would not be

0:12:15.320 --> 0:12:18.319
<v Speaker 1>conducted in the same way where you would withhold drugs

0:12:18.400 --> 0:12:21.480
<v Speaker 1>from one group, but at the time the evidence was

0:12:21.480 --> 0:12:24.680
<v Speaker 1>not as firm, especially for medication, and so that's why

0:12:24.720 --> 0:12:28.520
<v Speaker 1>it went forward. By the early nineteen eighties, after an

0:12:28.520 --> 0:12:31.920
<v Speaker 1>average of seven years follow up for each participant, the

0:12:32.000 --> 0:12:37.560
<v Speaker 1>results were in and they were unambiguous. Lowering blood cholesterol

0:12:37.640 --> 0:12:40.920
<v Speaker 1>in high risk men reduced the risk of heart attack.

0:12:41.520 --> 0:12:42.800
<v Speaker 3>Those who took period.

0:12:43.360 --> 0:12:45.880
<v Speaker 1>Those who took the full dose of treatment had a

0:12:45.880 --> 0:12:48.959
<v Speaker 1>thirty five percent reduction in total cholesterol and a forty

0:12:49.080 --> 0:12:53.200
<v Speaker 1>nine percent decline in the rate of cardiac events. But

0:12:53.559 --> 0:12:55.920
<v Speaker 1>even those who didn't follow the treatment to a t

0:12:56.520 --> 0:13:01.960
<v Speaker 1>like the cholestyramine, had lowered cholesterol in heart attacks. Now,

0:13:02.040 --> 0:13:05.320
<v Speaker 1>the study was not perfect, but when the results were

0:13:05.320 --> 0:13:08.640
<v Speaker 1>published in nineteen eighty three, it led to a moment

0:13:08.679 --> 0:13:11.079
<v Speaker 1>of reckoning for the field, like it was no longer

0:13:11.200 --> 0:13:15.840
<v Speaker 1>enough to simply acknowledge that this relationship exists. Something had

0:13:15.880 --> 0:13:19.680
<v Speaker 1>to be done about it right, and that's something was

0:13:19.720 --> 0:13:23.280
<v Speaker 1>to be decided at the nineteen eighty four NIH Consensus

0:13:23.280 --> 0:13:26.600
<v Speaker 1>Development Conference. So there was a panel of experts at

0:13:26.600 --> 0:13:28.840
<v Speaker 1>this conference who came up with a set of guidelines

0:13:28.880 --> 0:13:32.360
<v Speaker 1>for what would be considered high or low blood cholesterol

0:13:34.000 --> 0:13:37.200
<v Speaker 1>for certain ages and how that fell out, and also

0:13:37.360 --> 0:13:41.120
<v Speaker 1>diet and exercise recommendations for how to reduce cholesterol. They

0:13:41.200 --> 0:13:45.560
<v Speaker 1>also advocated for a nationwide educational program in which general

0:13:45.600 --> 0:13:48.560
<v Speaker 1>practitioners as well as the general public were taught about

0:13:48.559 --> 0:13:50.080
<v Speaker 1>the importance of cholesterol.

0:13:50.400 --> 0:13:51.959
<v Speaker 2>I love that. YEP.

0:13:52.400 --> 0:13:55.600
<v Speaker 1>This conference had a substantial impact over the next decade,

0:13:55.679 --> 0:14:00.079
<v Speaker 1>with the percentage of physicians pointing out LDL as an

0:14:00.080 --> 0:14:03.600
<v Speaker 1>important marker for the risk of heart disease that increased

0:14:03.960 --> 0:14:07.240
<v Speaker 1>from nineteen eighty six to nineteen ninety five, from thirty

0:14:07.280 --> 0:14:09.440
<v Speaker 1>four percent to seventy five percent.

0:14:10.360 --> 0:14:12.959
<v Speaker 2>So like in nineteen eighty six, only like.

0:14:12.960 --> 0:14:15.920
<v Speaker 1>Thirty percent said your physicials would be like.

0:14:16.520 --> 0:14:19.160
<v Speaker 2>Yeah, okay, and then ninety okay, ninety.

0:14:18.960 --> 0:14:20.920
<v Speaker 1>Five, and then it was seventy five percent in nineteen

0:14:21.000 --> 0:14:24.040
<v Speaker 1>ninety five, better than before, better than before. At the

0:14:24.120 --> 0:14:27.120
<v Speaker 1>time that the panel was making these recommendations, there still

0:14:27.360 --> 0:14:31.640
<v Speaker 1>wasn't really a good cholesterol lowering medication available, So the

0:14:31.640 --> 0:14:34.400
<v Speaker 1>one that they had used in the study, colostyramine, came

0:14:34.440 --> 0:14:37.240
<v Speaker 1>in a sandy powder which you had to mix into

0:14:37.280 --> 0:14:39.760
<v Speaker 1>water and consume throughout the day, so you had to

0:14:39.760 --> 0:14:42.280
<v Speaker 1>consume twenty four grams a day, was like the goal

0:14:42.440 --> 0:14:44.479
<v Speaker 1>in the study, which was like six.

0:14:44.280 --> 0:14:47.480
<v Speaker 3>Packets of this or something like that. No one's chasing that.

0:14:47.800 --> 0:14:49.200
<v Speaker 3>It was quite a heavy.

0:14:48.920 --> 0:14:51.800
<v Speaker 1>Lift, and it was made even more daunting by the

0:14:51.880 --> 0:14:55.280
<v Speaker 1>gi upset that it caused in many you know, bloating, diarrhea.

0:14:54.760 --> 0:14:55.960
<v Speaker 3>Constipation and stuff like that.

0:14:56.240 --> 0:14:59.920
<v Speaker 1>Yeah, so there was clearly a need for a safe, effective,

0:15:00.000 --> 0:15:05.160
<v Speaker 1>an easy medication to lower cholesterol. Fortunately, researchers were well

0:15:05.240 --> 0:15:09.240
<v Speaker 1>underway in their quest for such a wonder drug in

0:15:09.320 --> 0:15:13.720
<v Speaker 1>nineteen seventy one. The first hand account provider for this episode,

0:15:13.720 --> 0:15:17.000
<v Speaker 1>doctor Akira Endo, was working as a research biochemist at

0:15:17.000 --> 0:15:20.920
<v Speaker 1>the Japanese pharmaceutical company Sanchio when he got an idea.

0:15:21.680 --> 0:15:26.680
<v Speaker 1>Endo had long been fascinated with Alexander fleming serendipitous discovery

0:15:26.720 --> 0:15:30.920
<v Speaker 1>of penicillin, and after a research in New York, he

0:15:30.960 --> 0:15:35.440
<v Speaker 1>had become intrigued by this problem of hypercholesterolemia, and he

0:15:35.600 --> 0:15:41.600
<v Speaker 1>figured that, okay, if fungi produced antibacterial compounds like penicillin

0:15:41.720 --> 0:15:44.640
<v Speaker 1>to compete with other fungi, it's not like they produce

0:15:44.680 --> 0:15:47.200
<v Speaker 1>it because they're like, oh, humans could use this, No,

0:15:47.920 --> 0:15:52.440
<v Speaker 1>they right, it's part of the ecology.

0:15:52.320 --> 0:15:55.000
<v Speaker 3>Of their penicillium.

0:15:55.240 --> 0:15:57.560
<v Speaker 1>Then it's possible that they would produce other types of

0:15:57.600 --> 0:16:01.720
<v Speaker 1>compounds that would interfere with or help them compete against

0:16:01.800 --> 0:16:05.200
<v Speaker 1>fungi in other ways, such as maybe a compound that

0:16:05.600 --> 0:16:07.680
<v Speaker 1>interferes with cholesterol.

0:16:07.120 --> 0:16:13.360
<v Speaker 2>Collection because cholesterol is so essential for life. Yeah, fascinating. Yeah,

0:16:13.680 --> 0:16:17.000
<v Speaker 2>So he just was like, bro Fleming did this. Once

0:16:17.280 --> 0:16:21.480
<v Speaker 2>Fleming did this, Maybe there's I can find something here

0:16:21.600 --> 0:16:23.200
<v Speaker 2>because cholesterol is so important.

0:16:23.520 --> 0:16:25.760
<v Speaker 1>Yes, And he was, I mean part of the thing too.

0:16:25.800 --> 0:16:27.760
<v Speaker 1>He was like, he was like, fungi is all I knew.

0:16:28.240 --> 0:16:30.200
<v Speaker 1>So that's where I looked.

0:16:30.560 --> 0:16:30.840
<v Speaker 3>Hah.

0:16:31.120 --> 0:16:34.000
<v Speaker 1>But it also like that that logic is very clear,

0:16:34.080 --> 0:16:37.160
<v Speaker 1>but it had no direct support from any studies, Like

0:16:37.200 --> 0:16:39.920
<v Speaker 1>there was penicillin and the fact that we found other

0:16:39.960 --> 0:16:43.000
<v Speaker 1>antibiotics through this sort of like oh, this thing is

0:16:43.040 --> 0:16:48.600
<v Speaker 1>producing this thing that kills this bacteria or this fungi

0:16:48.680 --> 0:16:50.480
<v Speaker 1>in the environment, but like, yeah, but.

0:16:50.480 --> 0:16:53.040
<v Speaker 2>To think of it for use on cholesterol, like that's

0:16:53.040 --> 0:16:57.640
<v Speaker 2>so that's so interesting that his brain just did that right, Yeah.

0:16:57.720 --> 0:17:01.360
<v Speaker 3>And found he was right about it. Yeah. I mean,

0:17:01.400 --> 0:17:03.720
<v Speaker 3>so it took a while. It took two years.

0:17:03.840 --> 0:17:06.800
<v Speaker 1>He and his colleagues over that time screened six thousand

0:17:06.920 --> 0:17:11.320
<v Speaker 1>strains of microbes searching for a compound with cholesterol lowering

0:17:11.320 --> 0:17:15.159
<v Speaker 1>properties like searching for a needle in a haystack. Really wow,

0:17:15.400 --> 0:17:18.280
<v Speaker 1>And the first hit on this was less of a

0:17:18.320 --> 0:17:19.200
<v Speaker 1>needle and more of.

0:17:19.160 --> 0:17:22.960
<v Speaker 3>A crochet hook, but the second.

0:17:22.800 --> 0:17:26.320
<v Speaker 1>Was exactly what they were looking for. A compound came

0:17:26.480 --> 0:17:32.320
<v Speaker 1>from the mold penicillium citrinum with another penicillium, and they

0:17:32.400 --> 0:17:35.480
<v Speaker 1>named it Compactin, also known as mevastatin later.

0:17:35.640 --> 0:17:35.800
<v Speaker 2>Ok.

0:17:36.080 --> 0:17:41.760
<v Speaker 3>Yeah, and this was the first statin h Yeah.

0:17:41.920 --> 0:17:45.560
<v Speaker 1>So over the next several years, Endo and other researchers

0:17:45.560 --> 0:17:50.600
<v Speaker 1>at Sanchio tested compact in safety, efficacy, and commercial viability,

0:17:50.840 --> 0:17:55.320
<v Speaker 1>and other pharmaceutical companies got wind of this, like Merk,

0:17:55.400 --> 0:17:57.679
<v Speaker 1>who was like, can we get a sample of that

0:17:57.720 --> 0:17:59.520
<v Speaker 1>and see what's going on? And then they were like,

0:17:59.560 --> 0:18:01.320
<v Speaker 1>how did you find this? Well, we're going to look

0:18:01.359 --> 0:18:04.040
<v Speaker 1>for our own statin in the same way. They had

0:18:04.040 --> 0:18:07.240
<v Speaker 1>to kiss way fewer frogs, only eighteen before they found

0:18:07.320 --> 0:18:08.800
<v Speaker 1>their prints.

0:18:08.240 --> 0:18:10.600
<v Speaker 3>In LoVa statin in nineteen seventy eight.

0:18:11.160 --> 0:18:16.199
<v Speaker 1>Oh, competition, competition, Yeah, and then there's some there's like

0:18:16.240 --> 0:18:18.320
<v Speaker 1>a lot. There is so much more to the story

0:18:18.400 --> 0:18:23.040
<v Speaker 1>of like statin production, statin approval, statin testing, and stuff

0:18:23.080 --> 0:18:26.439
<v Speaker 1>like that, which I will have some papers there if

0:18:26.480 --> 0:18:29.359
<v Speaker 1>you want to dig more into that, Okay, But essentially,

0:18:29.640 --> 0:18:33.119
<v Speaker 1>there were some early trials and animals that hit some hiccups,

0:18:33.200 --> 0:18:36.359
<v Speaker 1>but then those were smoothed out. Trials and humans then

0:18:36.440 --> 0:18:40.240
<v Speaker 1>went forward in the early nineteen eighties and results were striking.

0:18:40.960 --> 0:18:45.240
<v Speaker 1>People with high cholesterol saw their LDL levels drop dramatically

0:18:45.400 --> 0:18:49.399
<v Speaker 1>after taking the medication with few side effects. But did

0:18:49.640 --> 0:18:53.439
<v Speaker 1>this drop translate to protection from cardiovascular disease?

0:18:53.840 --> 0:18:53.959
<v Speaker 2>Right?

0:18:54.680 --> 0:18:57.639
<v Speaker 3>You betcha yeah, you betcha yeah.

0:18:57.840 --> 0:18:58.080
<v Speaker 2>Yeah.

0:18:58.680 --> 0:19:01.240
<v Speaker 1>So there was one study sponsored by merk who was

0:19:01.240 --> 0:19:05.160
<v Speaker 1>testing out there statin found a forty two percent decrease

0:19:05.280 --> 0:19:08.199
<v Speaker 1>in death rate in those taking a statin. This is

0:19:08.240 --> 0:19:11.840
<v Speaker 1>the second generation statin, simvastatin.

0:19:11.280 --> 0:19:14.920
<v Speaker 2>Simvastatan still use it today, Yeah, wow Yeah.

0:19:15.040 --> 0:19:18.920
<v Speaker 1>Statins look to be the next blockbuster drug, and soon

0:19:19.240 --> 0:19:22.960
<v Speaker 1>every pharmaceutical company wanted in on the action, of course,

0:19:23.600 --> 0:19:26.359
<v Speaker 1>and by the last year of the nineteen eighties, three

0:19:26.440 --> 0:19:29.560
<v Speaker 1>statins were approved and available on the market.

0:19:29.880 --> 0:19:30.280
<v Speaker 2>Wow.

0:19:31.119 --> 0:19:34.720
<v Speaker 1>The following decade saw new statins and an expansion in

0:19:34.760 --> 0:19:38.400
<v Speaker 1>their use, which allowed for large scale clinical studies, not

0:19:38.600 --> 0:19:42.160
<v Speaker 1>just ones headed by pharmaceutical companies who were trying to

0:19:42.240 --> 0:19:46.320
<v Speaker 1>get their drug approved. Also just can't believe how recent

0:19:46.840 --> 0:19:47.399
<v Speaker 1>it all was.

0:19:47.600 --> 0:19:50.080
<v Speaker 2>Me neither. I really did not realize that this was

0:19:50.119 --> 0:19:53.719
<v Speaker 2>all in the last forty years since the nineteen eighties.

0:19:53.760 --> 0:19:54.880
<v Speaker 2>That's really wild.

0:19:55.080 --> 0:19:57.800
<v Speaker 1>It is wild, and I think it also is part

0:19:57.840 --> 0:20:00.000
<v Speaker 1>of the reason why there's been such controversy.

0:20:00.760 --> 0:20:05.480
<v Speaker 2>Hmmm. It's so interesting though, arin because there's so there's newer, newer,

0:20:05.600 --> 0:20:08.480
<v Speaker 2>newer drugs that I feel like have way less controversy

0:20:08.560 --> 0:20:09.560
<v Speaker 2>surrounding them.

0:20:09.640 --> 0:20:13.240
<v Speaker 1>I know, And I'm just like, what, I there's a lot,

0:20:13.280 --> 0:20:14.960
<v Speaker 1>there's a lot, and we're gonna we're gonna get into

0:20:14.960 --> 0:20:15.560
<v Speaker 1>it in a second.

0:20:15.840 --> 0:20:16.240
<v Speaker 2>Yeah.

0:20:16.240 --> 0:20:20.240
<v Speaker 1>But yeah, But these studies, these large scale studies that

0:20:20.240 --> 0:20:23.560
<v Speaker 1>were done not just by pharmaceutical industry, they conclusively and

0:20:23.680 --> 0:20:27.359
<v Speaker 1>consistently showed that statins were life saving drugs and that

0:20:27.400 --> 0:20:31.200
<v Speaker 1>they had earned their blockbuster status. Correct Across the board,

0:20:31.280 --> 0:20:34.040
<v Speaker 1>statins led to a twenty five to thirty percent reduction

0:20:34.119 --> 0:20:38.560
<v Speaker 1>in LDL coronary artery disease and death from cardiovascular disease.

0:20:39.560 --> 0:20:42.440
<v Speaker 1>In the forty or so years since statins have been

0:20:42.480 --> 0:20:46.080
<v Speaker 1>on the market, death from cardiovascular disease has dropped by

0:20:46.119 --> 0:20:50.159
<v Speaker 1>over seventy five percent in many industrialized countries. Statins are

0:20:50.200 --> 0:20:53.640
<v Speaker 1>a major tool in that fight, along with big advancements

0:20:53.640 --> 0:20:58.439
<v Speaker 1>in medicine, lifestyle modifications, and diagnostics. But of course the

0:20:58.480 --> 0:21:03.560
<v Speaker 1>story doesn't end here. The potential benefits of statins are enormous,

0:21:03.600 --> 0:21:08.080
<v Speaker 1>both at a population and individual level, especially with cardiovascular

0:21:08.119 --> 0:21:10.880
<v Speaker 1>disease being the leading cause of death in many countries.

0:21:11.840 --> 0:21:15.800
<v Speaker 1>But increasingly the benefits of these drugs are not realized

0:21:15.840 --> 0:21:20.080
<v Speaker 1>because people aren't taking statins when it's recommended that they do.

0:21:21.200 --> 0:21:22.600
<v Speaker 3>Why is that? Why?

0:21:23.240 --> 0:21:23.480
<v Speaker 2>Why?

0:21:24.119 --> 0:21:27.000
<v Speaker 1>As it turns out, it's for many different reasons. A

0:21:27.000 --> 0:21:29.800
<v Speaker 1>couple of recent papers looked into the issue and they

0:21:29.880 --> 0:21:33.240
<v Speaker 1>presented some themes that they found in why people either

0:21:33.320 --> 0:21:38.479
<v Speaker 1>refused or discontinued statins. There were, you know, practical and

0:21:38.600 --> 0:21:43.679
<v Speaker 1>logistical considerations, so concern about taking multiple medications, polypharmacy burden,

0:21:44.280 --> 0:21:47.719
<v Speaker 1>financial barriers, you know, having to drive to the clinic

0:21:47.800 --> 0:21:50.040
<v Speaker 1>to get low cost statins, things like that.

0:21:50.040 --> 0:21:54.440
<v Speaker 2>That's so annoying because they're all generic and not, especially

0:21:54.480 --> 0:21:56.560
<v Speaker 2>in this country, be high costpits that they are, and.

0:21:56.560 --> 0:21:58.399
<v Speaker 3>There should be you know, by mail et cetera.

0:21:58.600 --> 0:22:02.800
<v Speaker 1>Yeah, yeah, yeah, pregnancy and breastfeeding is another sort of

0:22:02.840 --> 0:22:07.320
<v Speaker 1>practical reason or preferring lifestyle modifications over a daily pill,

0:22:07.480 --> 0:22:09.000
<v Speaker 1>like I'm not gonna be able to take a pill

0:22:09.000 --> 0:22:12.080
<v Speaker 1>every single day, I'm gonna forget that. There were also

0:22:12.240 --> 0:22:17.560
<v Speaker 1>preconceptions about side effects or impact on someone's identity, so

0:22:17.760 --> 0:22:20.920
<v Speaker 1>people reported negative side effects or a fear of negative

0:22:20.920 --> 0:22:24.719
<v Speaker 1>side effects, and others felt that taking statins was like

0:22:25.000 --> 0:22:28.080
<v Speaker 1>giving up, that it signified sickness, and that they didn't

0:22:28.080 --> 0:22:29.800
<v Speaker 1>want to be on a medication for the rest of

0:22:29.800 --> 0:22:31.560
<v Speaker 1>their life. They didn't want to be dependent on this

0:22:31.680 --> 0:22:37.040
<v Speaker 1>drug for health. And then there was another big reason

0:22:37.280 --> 0:22:40.880
<v Speaker 1>or another big theme was mistrust in medicine and kind

0:22:40.880 --> 0:22:44.040
<v Speaker 1>of a lack of understanding or belief in the drugs

0:22:44.160 --> 0:22:48.399
<v Speaker 1>and how they worked, so some questioned their utility. Like

0:22:48.640 --> 0:22:51.040
<v Speaker 1>I have high cholesterol. The doc says, I have high cholesterol,

0:22:51.119 --> 0:22:54.680
<v Speaker 1>but I don't feel bad. Statins doesn't make me feel

0:22:54.680 --> 0:22:56.840
<v Speaker 1>any different or it makes me feel worse.

0:22:57.160 --> 0:22:59.200
<v Speaker 2>Right, I have this side effect that came from it,

0:22:59.320 --> 0:23:03.240
<v Speaker 2>I think, And I didn't feel bad to begin with, right, exactly,

0:23:03.440 --> 0:23:05.200
<v Speaker 2>why would I be on a medicine forever?

0:23:06.680 --> 0:23:10.960
<v Speaker 1>People didn't also understand how statins lowered cholesterol, so it

0:23:11.000 --> 0:23:12.359
<v Speaker 1>was just sort of like, well, I don't understand how

0:23:12.359 --> 0:23:14.879
<v Speaker 1>they work, so I don't know that they do work.

0:23:15.520 --> 0:23:19.080
<v Speaker 1>And many people also questioned the motives of doctors in

0:23:19.200 --> 0:23:22.680
<v Speaker 1>prescribing the medication, like big Pharma has a hand in this,

0:23:23.080 --> 0:23:26.240
<v Speaker 1>and they felt that over prescribing was an issue, especially

0:23:26.280 --> 0:23:29.639
<v Speaker 1>with levels being revisited every so often and being like,

0:23:29.760 --> 0:23:32.520
<v Speaker 1>now we recommend that you're you know, you didn't recommend

0:23:32.560 --> 0:23:34.360
<v Speaker 1>me last year when my ELDALE.

0:23:33.960 --> 0:23:37.080
<v Speaker 2>Was the same exactly. Now we need your LDAL to

0:23:37.080 --> 0:23:39.000
<v Speaker 2>be less than seventy. Now we needed to be less

0:23:39.000 --> 0:23:42.359
<v Speaker 2>than fifty five now, yeah, without a good explanation. They

0:23:42.480 --> 0:23:45.920
<v Speaker 2>just updated the guidelines in March of this year, so

0:23:46.119 --> 0:23:47.440
<v Speaker 2>they're changed yet again.

0:23:47.760 --> 0:23:50.399
<v Speaker 1>Right, So there's this sort of fear of like diagnostic creep.

0:23:50.640 --> 0:23:53.920
<v Speaker 1>Is that happening with cholesterol and statins or is there

0:23:54.000 --> 0:23:59.200
<v Speaker 1>evidence to support this shifting of the levels and the recommendations.

0:24:00.040 --> 0:24:03.159
<v Speaker 1>But often with all of these different reasons, it was

0:24:03.160 --> 0:24:06.240
<v Speaker 1>a combination of things that led people to either refuse

0:24:06.280 --> 0:24:08.600
<v Speaker 1>statins or stop taking them.

0:24:09.040 --> 0:24:11.280
<v Speaker 3>Within two years, roughly.

0:24:11.000 --> 0:24:13.879
<v Speaker 1>Forty percent of people who were taking them for primary

0:24:13.920 --> 0:24:16.760
<v Speaker 1>prevention and twenty five percent of people on statins for

0:24:16.840 --> 0:24:21.240
<v Speaker 1>secondary prevention end up stopping the medication. So to say

0:24:21.240 --> 0:24:24.720
<v Speaker 1>that these negative attitudes towards statins are worrisome, I think

0:24:24.840 --> 0:24:29.439
<v Speaker 1>is quite an understatement. It could have serious, even fatal consequences.

0:24:30.240 --> 0:24:33.080
<v Speaker 1>So what do we do about it? The first step

0:24:33.200 --> 0:24:37.800
<v Speaker 1>is understanding why, you know, where are these attitudes these

0:24:37.840 --> 0:24:42.080
<v Speaker 1>beliefs coming from. Many of the reasons that people give

0:24:42.240 --> 0:24:46.239
<v Speaker 1>for not taking or discontinuing statins can be attributed in

0:24:46.320 --> 0:24:52.040
<v Speaker 1>part to misinformations or negative beliefs promoted across social media.

0:24:53.119 --> 0:24:55.800
<v Speaker 1>When statins first came on the market in the late

0:24:55.880 --> 0:24:59.920
<v Speaker 1>nineteen eighties, the cholesterol heart disease link had not yet

0:25:00.080 --> 0:25:03.280
<v Speaker 1>been fully embraced by the general public, and in fact,

0:25:03.359 --> 0:25:07.120
<v Speaker 1>there were some highly publicized front page stories written by

0:25:07.240 --> 0:25:13.840
<v Speaker 1>vocal deniers controversy cells, consensus doesn't yes. And so all

0:25:13.840 --> 0:25:16.280
<v Speaker 1>of a sudden, you go to the doctor. Your doctor

0:25:16.359 --> 0:25:18.480
<v Speaker 1>is telling you should take this drug for your cholesterol.

0:25:18.480 --> 0:25:20.960
<v Speaker 1>But just that morning you read how the cholesterol heart

0:25:20.960 --> 0:25:23.560
<v Speaker 1>disease link is overblown so that big Pharma can rake

0:25:23.600 --> 0:25:25.200
<v Speaker 1>in the dough and get people on meds for life.

0:25:25.920 --> 0:25:26.720
<v Speaker 3>Why would you do this?

0:25:27.080 --> 0:25:32.240
<v Speaker 1>Right? And it would take years after statins were introduced

0:25:32.280 --> 0:25:34.840
<v Speaker 1>to put together those big data sets that show the

0:25:34.840 --> 0:25:37.760
<v Speaker 1>life saving benefits of the drugs and the relatively low

0:25:37.880 --> 0:25:40.960
<v Speaker 1>rate of side effects. And so doubt has really been

0:25:41.320 --> 0:25:45.320
<v Speaker 1>sewn into statins from the very beginning, along with a

0:25:45.400 --> 0:25:48.600
<v Speaker 1>mistrust in how the pharmaceutical industry is involved.

0:25:49.040 --> 0:25:50.240
<v Speaker 3>And I get it, like.

0:25:50.280 --> 0:25:55.880
<v Speaker 1>There is some truth to this involvement, especially early drug

0:25:55.920 --> 0:26:00.040
<v Speaker 1>trials being designed by pharmaceutical companies. Many researchers in this

0:26:00.119 --> 0:26:03.800
<v Speaker 1>area hold board positions or received funding from these companies

0:26:03.920 --> 0:26:06.680
<v Speaker 1>or have a patent for these drugs, and they're trying,

0:26:06.760 --> 0:26:08.960
<v Speaker 1>you know, like there is there are financial ties that

0:26:09.000 --> 0:26:10.520
<v Speaker 1>are undeniable.

0:26:09.960 --> 0:26:12.400
<v Speaker 2>One hundred percent, one hundred percent. And I will say

0:26:12.800 --> 0:26:16.400
<v Speaker 2>like in today's day in age, not just with pharmaceutical companies,

0:26:16.440 --> 0:26:21.160
<v Speaker 2>also with radiology companies and imaging companies and genetic testing companies,

0:26:21.200 --> 0:26:23.840
<v Speaker 2>and so as our guidelines shift to incorporate more of these,

0:26:23.920 --> 0:26:28.919
<v Speaker 2>like it is very valid to question these conflicts of interests,

0:26:28.920 --> 0:26:31.120
<v Speaker 2>whether they are real or perceived, Like they.

0:26:30.960 --> 0:26:34.600
<v Speaker 1>Matter, they matter, they do matter, And I think that

0:26:34.720 --> 0:26:37.640
<v Speaker 1>this is, like you said, as these as these guidelines

0:26:37.640 --> 0:26:41.320
<v Speaker 1>are shifting, there's these questions around like who, what's what's

0:26:41.359 --> 0:26:43.439
<v Speaker 1>behind these guidelines, is there evidence for it?

0:26:43.520 --> 0:26:44.000
<v Speaker 3>Et cetera.

0:26:45.200 --> 0:26:48.520
<v Speaker 1>At the same time, decades of statin research. These drugs

0:26:48.520 --> 0:26:50.520
<v Speaker 1>have been around for almost forty.

0:26:50.359 --> 0:26:51.240
<v Speaker 2>Years forty years now.

0:26:51.320 --> 0:26:55.720
<v Speaker 1>Yeah, decades of research have proven the value of statins,

0:26:55.760 --> 0:26:58.960
<v Speaker 1>and that research is not solely conducted by industry, but

0:26:59.440 --> 0:27:02.679
<v Speaker 1>large scale work being done across the globe, not just

0:27:02.720 --> 0:27:04.720
<v Speaker 1>within pharmaceutical sectors in the United.

0:27:04.520 --> 0:27:06.080
<v Speaker 3>States, but across the globe.

0:27:06.480 --> 0:27:09.560
<v Speaker 1>And while yes, of course pharmaceutical companies love a drug

0:27:09.600 --> 0:27:11.960
<v Speaker 1>that someone has to take for long periods of time,

0:27:12.480 --> 0:27:15.960
<v Speaker 1>many statins today are available in a generic form, and

0:27:16.000 --> 0:27:18.840
<v Speaker 1>so they're not as profitable as they once were. In

0:27:18.880 --> 0:27:21.919
<v Speaker 1>any case, your primary care doc is not getting a

0:27:22.000 --> 0:27:25.080
<v Speaker 1>kickback from prescribing these drugs. They simply don't want you

0:27:25.119 --> 0:27:26.280
<v Speaker 1>to die from heart disease.

0:27:28.680 --> 0:27:30.439
<v Speaker 2>It's so truely Arian, that's true.

0:27:30.480 --> 0:27:32.159
<v Speaker 3>It's true. Okay.

0:27:32.200 --> 0:27:36.639
<v Speaker 1>Another big reason that people cited was side effects, including

0:27:36.840 --> 0:27:40.240
<v Speaker 1>or specifically muscle symptoms. This is one of the top

0:27:40.280 --> 0:27:43.879
<v Speaker 1>reasons that people stop taking or never start taking statins.

0:27:44.520 --> 0:27:47.720
<v Speaker 1>Side Effects are real and important to take seriously because

0:27:47.760 --> 0:27:51.399
<v Speaker 1>they can truly impact quality of life. But the story

0:27:51.400 --> 0:27:54.680
<v Speaker 1>of side effects when it comes to statins is complicated.

0:27:55.240 --> 0:27:56.560
<v Speaker 3>Until two thousand.

0:27:56.200 --> 0:28:00.560
<v Speaker 1>And one, there were very few reports of tolerability or

0:28:00.640 --> 0:28:04.000
<v Speaker 1>safety concerns for people taking statins, but that year a

0:28:04.040 --> 0:28:09.440
<v Speaker 1>statin seruvastatin, was removed from the market due to safety concerns,

0:28:09.560 --> 0:28:13.000
<v Speaker 1>specifically for rahpdomiel issis, which occurred at a rate of

0:28:13.359 --> 0:28:15.960
<v Speaker 1>zero point zero one percent in people.

0:28:15.720 --> 0:28:16.760
<v Speaker 3>Taking it okay.

0:28:17.280 --> 0:28:20.880
<v Speaker 1>Promptly after its removal from the market, all information sheets

0:28:20.880 --> 0:28:25.400
<v Speaker 1>included warnings about all for all statins included warnings about

0:28:25.440 --> 0:28:29.760
<v Speaker 1>muscle symptoms, and physicians counseled patients to report muscle aches

0:28:29.800 --> 0:28:34.240
<v Speaker 1>as an early warning sign of rahpdomiel issis. This issue

0:28:34.240 --> 0:28:36.560
<v Speaker 1>was highly publicized, as it should have been. You know,

0:28:36.640 --> 0:28:38.920
<v Speaker 1>this is a potentially serious side effect, and so let's

0:28:39.040 --> 0:28:41.280
<v Speaker 1>you know, make sure you look out for this. And

0:28:41.480 --> 0:28:45.160
<v Speaker 1>many patients who felt muscle aches often would interpret them

0:28:45.200 --> 0:28:48.480
<v Speaker 1>as myopathy or go to their doctor with concerns about myopathy.

0:28:48.960 --> 0:28:52.640
<v Speaker 1>They would stop taking statins and their symptoms improved, which

0:28:52.800 --> 0:28:56.640
<v Speaker 1>reinforced the belief that these statins might be dangerous, right,

0:28:56.920 --> 0:28:58.920
<v Speaker 1>or the cause of that the cause of that? Right,

0:28:58.960 --> 0:29:03.160
<v Speaker 1>And certainly these muscle symptoms were and are real, But

0:29:03.240 --> 0:29:07.320
<v Speaker 1>there is also something called the nocibo effect that seems

0:29:07.360 --> 0:29:09.960
<v Speaker 1>to be at play here, at least to some degree.

0:29:10.440 --> 0:29:13.680
<v Speaker 3>So the nocebo effect is the opposite of the placebo effect.

0:29:14.000 --> 0:29:18.240
<v Speaker 1>It's anticipation of negative symptoms that leads you to experience them.

0:29:19.160 --> 0:29:22.640
<v Speaker 1>Studies on statins have shown that when both researcher and

0:29:22.880 --> 0:29:27.240
<v Speaker 1>patient don't know whether someone is getting medication statin or placebo,

0:29:27.920 --> 0:29:32.440
<v Speaker 1>both control and treatment groups experience similar rates of muscle aches,

0:29:33.040 --> 0:29:36.520
<v Speaker 1>which suggests that it might not be the statins themselves

0:29:36.680 --> 0:29:39.560
<v Speaker 1>directly responsible for those symptoms.

0:29:39.880 --> 0:29:41.680
<v Speaker 3>Right, At least in all.

0:29:41.560 --> 0:29:45.760
<v Speaker 1>Cases, the symptoms are absolutely real. The nocibo effect does

0:29:45.760 --> 0:29:48.440
<v Speaker 1>not mean that it's all in your head. You're experiencing

0:29:48.600 --> 0:29:51.800
<v Speaker 1>these symptoms. They just might not always be caused by

0:29:51.840 --> 0:29:52.840
<v Speaker 1>the drug itself.

0:29:53.040 --> 0:29:55.720
<v Speaker 2>Right. It's not like there's a direct mechanistic link between

0:29:55.800 --> 0:30:01.160
<v Speaker 2>the drug that is directly causing that muscle symptom necessarily, right.

0:30:01.440 --> 0:30:03.040
<v Speaker 3>But it could be.

0:30:03.200 --> 0:30:05.360
<v Speaker 1>It could like, and so this is where it's really

0:30:05.400 --> 0:30:08.400
<v Speaker 1>really tricky to tease apart both the patient and provider.

0:30:08.800 --> 0:30:11.360
<v Speaker 1>And so it might be just like, feel like the

0:30:11.400 --> 0:30:13.680
<v Speaker 1>easiest course to go, I'm just going to stop because

0:30:13.680 --> 0:30:15.320
<v Speaker 1>I don't want to feel this way. I don't want to.

0:30:15.360 --> 0:30:17.760
<v Speaker 1>I'm worried about this, and this is hurting my quality

0:30:17.800 --> 0:30:22.280
<v Speaker 1>of life. I'm going to stop. Other research has also

0:30:22.320 --> 0:30:25.240
<v Speaker 1>shown that people who are exposed to more negative stories

0:30:25.320 --> 0:30:29.280
<v Speaker 1>surrounding statins and side effects are more likely to discontinue use.

0:30:30.040 --> 0:30:33.280
<v Speaker 1>And I think that what's also at play here is

0:30:33.440 --> 0:30:35.160
<v Speaker 1>when we kind of touched on this, is that we

0:30:35.240 --> 0:30:38.240
<v Speaker 1>don't feel high cholesterol like, we don't feel any different

0:30:38.240 --> 0:30:41.960
<v Speaker 1>when our cholesterol is low, but we do expect a

0:30:41.960 --> 0:30:45.000
<v Speaker 1>lot of the time that the medications we take will

0:30:45.040 --> 0:30:48.280
<v Speaker 1>make us feel different. We're supposed to feel better from

0:30:48.320 --> 0:30:52.440
<v Speaker 1>these medications, supposed to feel something something yeah, yeah, And

0:30:52.520 --> 0:30:55.280
<v Speaker 1>so it makes sense that if you read horror stories

0:30:55.280 --> 0:30:57.720
<v Speaker 1>about side effects of statins that abound on the internet,

0:30:57.760 --> 0:31:01.200
<v Speaker 1>you're predisposed to expect that those bad outcomes will happen

0:31:01.240 --> 0:31:04.640
<v Speaker 1>to you. And what doesn't help this is that there

0:31:04.720 --> 0:31:08.480
<v Speaker 1>is a vast amount of misinformation and disinformation about statins

0:31:08.480 --> 0:31:12.840
<v Speaker 1>circulating on social media and generative AI. There's a motive

0:31:12.920 --> 0:31:16.200
<v Speaker 1>for people to be spreading some of this misin disinformation.

0:31:16.960 --> 0:31:19.720
<v Speaker 1>So in fact, there was a recent study that showed

0:31:19.720 --> 0:31:24.160
<v Speaker 1>that many generative AI models, when fed prompts asking about statins,

0:31:24.280 --> 0:31:28.120
<v Speaker 1>especially if those prompts were leading sort of like what

0:31:28.160 --> 0:31:29.160
<v Speaker 1>can I take things?

0:31:29.560 --> 0:31:33.280
<v Speaker 2>Isn't there some evidence of these side effects with statins

0:31:33.280 --> 0:31:35.080
<v Speaker 2>like those kinds of questions.

0:31:34.760 --> 0:31:38.360
<v Speaker 1>Yeah yeah, or like what should I take that's safer

0:31:38.400 --> 0:31:41.080
<v Speaker 1>than statins? Like what natural product should I take that

0:31:41.120 --> 0:31:44.680
<v Speaker 1>are that's safer than statins. But many of these models

0:31:44.760 --> 0:31:47.120
<v Speaker 1>gave inappropriate and inaccurate answers.

0:31:47.320 --> 0:31:49.160
<v Speaker 2>That doesn't surprise me at all, right.

0:31:49.240 --> 0:31:52.000
<v Speaker 1>Right, the sheer amount of misinformation that's out there and

0:31:52.680 --> 0:31:56.600
<v Speaker 1>just sort of the overall decline or disregard of expertise

0:31:56.640 --> 0:31:58.280
<v Speaker 1>that's happening around the globe.

0:31:58.680 --> 0:31:59.520
<v Speaker 3>Yeah there.

0:31:59.520 --> 0:32:02.080
<v Speaker 1>And then there are the people who are very vocal

0:32:02.280 --> 0:32:04.800
<v Speaker 1>in their opposition to statins, that at the same time

0:32:04.880 --> 0:32:07.800
<v Speaker 1>are telling you don't go on statins, buy my red

0:32:07.880 --> 0:32:12.240
<v Speaker 1>yeast rice supplement instead, or buy this diet book, or

0:32:12.640 --> 0:32:14.720
<v Speaker 1>they're trying to make money off of you in some way,

0:32:14.880 --> 0:32:17.120
<v Speaker 1>you know, subscribe to my sub stack that says, you know,

0:32:17.240 --> 0:32:20.480
<v Speaker 1>day one diet with me, and right, I'll tell you

0:32:20.520 --> 0:32:24.400
<v Speaker 1>throw away your statins, Yeah yeah, And that the thing

0:32:24.520 --> 0:32:27.000
<v Speaker 1>is like I also understand why that's appealing when you've

0:32:27.040 --> 0:32:29.640
<v Speaker 1>been dismissed by your physician, or your physician is saying

0:32:29.720 --> 0:32:32.600
<v Speaker 1>it's not the statin causing this, just like that simply

0:32:32.640 --> 0:32:35.520
<v Speaker 1>across the board, or if you can't even afford to

0:32:35.560 --> 0:32:39.520
<v Speaker 1>go see a doctor, right, this this information is out there,

0:32:39.520 --> 0:32:43.880
<v Speaker 1>and that is filling a hole that you want.

0:32:44.560 --> 0:32:46.920
<v Speaker 2>And it feels like you're being taken seriously for the

0:32:46.960 --> 0:32:49.280
<v Speaker 2>first time when you're like I went to my doctor

0:32:49.320 --> 0:32:51.400
<v Speaker 2>with these concerns and you were totally dismissed or they

0:32:51.400 --> 0:32:54.840
<v Speaker 2>were like, oh, you're fine, right, I'm not fine if

0:32:54.840 --> 0:32:56.520
<v Speaker 2>I'm having symptoms, right.

0:32:56.480 --> 0:32:59.440
<v Speaker 1>Yeah, And I mean again, like all of this, I

0:32:59.480 --> 0:33:03.560
<v Speaker 1>think what it does is it speaks to a need

0:33:03.800 --> 0:33:07.480
<v Speaker 1>to more closely examine the side effects that people report,

0:33:07.600 --> 0:33:09.840
<v Speaker 1>not just muscle symptoms, but the other side effects that

0:33:09.840 --> 0:33:13.360
<v Speaker 1>people report, and how best to address them, how best

0:33:13.400 --> 0:33:16.280
<v Speaker 1>to measure them, How can we make it so that

0:33:16.360 --> 0:33:20.440
<v Speaker 1>people can take drugs that will lower cholesterol and potentially

0:33:20.440 --> 0:33:24.400
<v Speaker 1>save their lives. So again, what do we do about it?

0:33:24.720 --> 0:33:27.400
<v Speaker 1>And I think that as a start, we can look

0:33:27.440 --> 0:33:31.320
<v Speaker 1>at the reasons people take statons. So that same systematic

0:33:31.360 --> 0:33:35.040
<v Speaker 1>review that I mentioned earlier also showed many people have

0:33:35.200 --> 0:33:39.960
<v Speaker 1>positive sentiment towards these drugs. They trust their efficacy, like

0:33:40.400 --> 0:33:43.280
<v Speaker 1>look how much my bad cholesterol dropped and my good

0:33:43.360 --> 0:33:48.320
<v Speaker 1>cholesterol rose. They report that their health anxiety has eased

0:33:48.480 --> 0:33:51.960
<v Speaker 1>thanks to the drugs, reporting an enhanced peace of mind,

0:33:52.840 --> 0:33:56.440
<v Speaker 1>and they view them also as a way of taking

0:33:56.520 --> 0:34:02.080
<v Speaker 1>control and ensuring a better, healthier future. Rebrand these drugs

0:34:02.120 --> 0:34:05.600
<v Speaker 1>for what they are heart attack prevention, stroke prevention, a

0:34:05.640 --> 0:34:08.719
<v Speaker 1>way to extend your life, your quality of life, and

0:34:08.800 --> 0:34:12.080
<v Speaker 1>spend more time with the people you love, accomplishing all

0:34:12.120 --> 0:34:13.000
<v Speaker 1>the things.

0:34:12.760 --> 0:34:13.520
<v Speaker 3>You want to do.

0:34:14.400 --> 0:34:17.600
<v Speaker 1>These drugs might not make you feel any better instantaneously,

0:34:17.920 --> 0:34:20.640
<v Speaker 1>but they will make it more likely that you're around

0:34:20.680 --> 0:34:24.640
<v Speaker 1>to feel and do things ten years from now. Having

0:34:24.719 --> 0:34:27.480
<v Speaker 1>high cholesterol it doesn't mean that you have failed. It

0:34:27.520 --> 0:34:30.279
<v Speaker 1>should not be seen as shameful, as something that you

0:34:30.320 --> 0:34:34.839
<v Speaker 1>should hide or feel embarrassed by, and taking these medications

0:34:34.840 --> 0:34:37.480
<v Speaker 1>should make you feel like you're taking agency over your

0:34:37.480 --> 0:34:41.240
<v Speaker 1>own life. Prevention is always harder, especially when the threat

0:34:41.440 --> 0:34:43.920
<v Speaker 1>like a heart attack, doesn't seem imminent or is so

0:34:44.040 --> 0:34:45.960
<v Speaker 1>scary that you're like, I have to think that this

0:34:46.000 --> 0:34:47.040
<v Speaker 1>won't happen to me.

0:34:47.880 --> 0:34:50.040
<v Speaker 2>I can't put my mind in that place.

0:34:50.320 --> 0:34:54.160
<v Speaker 1>Yes, but that denial it really does not serve us well.

0:34:54.440 --> 0:34:56.319
<v Speaker 1>And so with that eron, I'm going to turn it

0:34:56.360 --> 0:34:59.120
<v Speaker 1>over to you to tell us about how statins actually

0:34:59.160 --> 0:35:02.640
<v Speaker 1>work and where things stand with cardiovascular disease around the

0:35:02.680 --> 0:35:03.520
<v Speaker 1>globe today.

0:35:04.000 --> 0:35:26.080
<v Speaker 2>I would love to so knowing that statins have made

0:35:26.120 --> 0:35:29.160
<v Speaker 2>such a huge impact, or have the potential at least

0:35:29.200 --> 0:35:32.239
<v Speaker 2>to make such a huge impact on disease, I think

0:35:32.280 --> 0:35:34.120
<v Speaker 2>we first need to understand a little bit more about

0:35:34.120 --> 0:35:37.560
<v Speaker 2>how they work. So I want to go through not

0:35:37.680 --> 0:35:42.200
<v Speaker 2>just statins, but the strategies overall that we use today

0:35:42.320 --> 0:35:49.000
<v Speaker 2>to lower LDL cholesterol, specifically how these strategies work, and

0:35:49.040 --> 0:35:51.560
<v Speaker 2>then I want to wrap up by giving us all

0:35:51.600 --> 0:35:55.880
<v Speaker 2>like a reminder of why lowering cholesterol is so important,

0:35:55.920 --> 0:36:00.960
<v Speaker 2>by looking at athrosclerotic heart disease kind of across the globe. Okay,

0:36:02.239 --> 0:36:04.000
<v Speaker 2>And so the first thing to know is that while

0:36:04.040 --> 0:36:07.480
<v Speaker 2>statins are because of how long they've been around and

0:36:07.560 --> 0:36:11.160
<v Speaker 2>because of how strong the evidence is that they are

0:36:11.360 --> 0:36:15.400
<v Speaker 2>extremely effective not just at lowering that cholesterol, but actually

0:36:15.480 --> 0:36:19.879
<v Speaker 2>at preventing heart attack, stroke and death. They are a

0:36:19.920 --> 0:36:24.920
<v Speaker 2>mainstay of therapy today for cholesterol management, but they are

0:36:24.960 --> 0:36:28.520
<v Speaker 2>not the only thing that we have. And the first

0:36:28.600 --> 0:36:32.480
<v Speaker 2>thing that is always recommended across the board is diet

0:36:32.520 --> 0:36:36.399
<v Speaker 2>and lifestyle changes. And the thing is that we do

0:36:36.520 --> 0:36:40.719
<v Speaker 2>have really decent data as far as nutrition data goes,

0:36:40.760 --> 0:36:44.600
<v Speaker 2>which we all know is limited. Yep, we do have

0:36:44.680 --> 0:36:48.400
<v Speaker 2>decent data that lifestyle changes can work for a lot

0:36:48.440 --> 0:36:52.160
<v Speaker 2>of people. But the problem is that we also know

0:36:52.520 --> 0:36:58.200
<v Speaker 2>that your total cholesterol and your LDL cholesterol, so the

0:36:58.560 --> 0:37:04.480
<v Speaker 2>packages of LDL cholesterol are not entirely driven by your diet.

0:37:04.960 --> 0:37:08.640
<v Speaker 2>They're not entirely driven by how much exercise you're getting, right.

0:37:09.040 --> 0:37:12.600
<v Speaker 2>There are a lot of different things that go into

0:37:12.760 --> 0:37:16.120
<v Speaker 2>determining what your cholesterol levels are and whether they are

0:37:16.200 --> 0:37:18.839
<v Speaker 2>high or whether they are low. And one of the

0:37:19.000 --> 0:37:23.440
<v Speaker 2>big things is our genetics. You talked in last week's

0:37:23.440 --> 0:37:28.399
<v Speaker 2>episode AARIN about familial hypercholesterolemia. This is one or really

0:37:28.440 --> 0:37:33.319
<v Speaker 2>kind of like one group of disorders that can seriously

0:37:33.400 --> 0:37:39.520
<v Speaker 2>contribute to elevated cholesterol, especially LDL cholesterol. But it's not

0:37:39.600 --> 0:37:42.160
<v Speaker 2>the only one. There are a whole bunch of other

0:37:42.400 --> 0:37:46.759
<v Speaker 2>genetic contributions, whether that's multiple genes or things that we

0:37:46.800 --> 0:37:49.359
<v Speaker 2>don't even know yet, right, Genes that we haven't even

0:37:49.400 --> 0:37:53.600
<v Speaker 2>discovered yet that are associated with the ratios and amounts

0:37:53.600 --> 0:37:57.200
<v Speaker 2>of cholesterol, whether that's because these genes affect how we

0:37:57.320 --> 0:38:02.080
<v Speaker 2>recycle cholesterol, whether they affect how much cholesterol we produce

0:38:02.120 --> 0:38:06.680
<v Speaker 2>in our liver, or whether like in familial hypercholesterolemia, they

0:38:06.680 --> 0:38:10.080
<v Speaker 2>affect our LDL receptors and how good our cells are

0:38:10.200 --> 0:38:13.439
<v Speaker 2>at taking that cholesterol out of our bloodstream right, right,

0:38:14.239 --> 0:38:16.040
<v Speaker 2>So all of these things are going to play a

0:38:16.120 --> 0:38:19.880
<v Speaker 2>role as well as our dietary factors and our lifestyle factors,

0:38:19.880 --> 0:38:23.240
<v Speaker 2>and so that is usually the first thing that any

0:38:23.360 --> 0:38:26.920
<v Speaker 2>physician is going to recommend if someone's cholesterol is elevated,

0:38:27.239 --> 0:38:31.960
<v Speaker 2>is can we bring this down by reducing or stopping

0:38:32.000 --> 0:38:34.600
<v Speaker 2>smoking if you smoke, because that has a huge effect

0:38:34.840 --> 0:38:37.040
<v Speaker 2>Lowering the amount of alcohol that you drink, which is

0:38:37.080 --> 0:38:40.479
<v Speaker 2>going to help to lower your cholesterol levels. Switching out

0:38:40.640 --> 0:38:45.200
<v Speaker 2>saturated fats in your diet for unsaturated fats, right, switching

0:38:45.200 --> 0:38:49.040
<v Speaker 2>out animal products for plant products. These are the kinds

0:38:49.080 --> 0:38:53.200
<v Speaker 2>of dietary changes that we have good data to say

0:38:53.239 --> 0:38:57.759
<v Speaker 2>that not only do they reduce your cholesterol levels, but

0:38:57.800 --> 0:39:01.960
<v Speaker 2>they also can actually prevent cardiovascular disease. We have that data,

0:39:02.040 --> 0:39:07.120
<v Speaker 2>it exists, but for many people that isn't sufficient, and

0:39:07.160 --> 0:39:11.799
<v Speaker 2>so that is when it is recommended that medication is

0:39:11.800 --> 0:39:15.320
<v Speaker 2>actually used, right, whether it's because somebody can't or doesn't

0:39:15.360 --> 0:39:18.840
<v Speaker 2>want to change their diet or exercise, or they can't

0:39:18.880 --> 0:39:22.000
<v Speaker 2>increase physical activity, or they are literally already doing the

0:39:22.000 --> 0:39:26.280
<v Speaker 2>most and it's still not enough. And that happens so

0:39:26.280 --> 0:39:27.600
<v Speaker 2>so so often.

0:39:27.400 --> 0:39:29.440
<v Speaker 1>Right, And I think it's like, this is where I

0:39:29.480 --> 0:39:32.480
<v Speaker 1>feel like it can feel like I have failed or

0:39:33.000 --> 0:39:35.520
<v Speaker 1>I thought I was trying my best to do all

0:39:35.560 --> 0:39:37.760
<v Speaker 1>these things and still it's not working.

0:39:37.880 --> 0:39:38.440
<v Speaker 3>And it's like.

0:39:38.440 --> 0:39:42.120
<v Speaker 1>That that's okay, Like this is not your no, you're

0:39:42.160 --> 0:39:43.520
<v Speaker 1>not a failure of No.

0:39:43.840 --> 0:39:46.680
<v Speaker 2>Yeah, no, it's that's so true, Aaron, Like I see

0:39:46.680 --> 0:39:48.719
<v Speaker 2>people in clinic all the time that this happens too,

0:39:48.840 --> 0:39:51.719
<v Speaker 2>and I just say, blame your parents, like it's probably

0:39:51.800 --> 0:39:57.200
<v Speaker 2>your genes. Okay. So let's then talk about what are

0:39:57.440 --> 0:39:59.640
<v Speaker 2>some of the big medicines that we use and how

0:39:59.719 --> 0:40:04.759
<v Speaker 2>do they actually work. Why are they working? Yes, yes, statins.

0:40:05.840 --> 0:40:05.960
<v Speaker 3>So.

0:40:06.239 --> 0:40:11.440
<v Speaker 2>Statins block an enzyme in our liver that's called hmg

0:40:11.680 --> 0:40:16.240
<v Speaker 2>CoA reductase. The cliff Notes version is that this particular enzyme,

0:40:16.480 --> 0:40:22.760
<v Speaker 2>hmg CoA reductase, this one is the rate limiting step

0:40:23.160 --> 0:40:27.440
<v Speaker 2>in cholesterol synthesis in your liver, so that enzyme is

0:40:27.520 --> 0:40:30.400
<v Speaker 2>necessary in our liver for our liver to make cholesterol.

0:40:30.400 --> 0:40:33.520
<v Speaker 2>And remember, our liver is making over fifty percent of

0:40:33.560 --> 0:40:35.360
<v Speaker 2>the cholesterol floating around in our body.

0:40:35.440 --> 0:40:38.560
<v Speaker 1>Right, so you have if you have more hmg CoA reductase,

0:40:38.640 --> 0:40:40.920
<v Speaker 1>then you have more cholesterol photogram in your body. If

0:40:40.960 --> 0:40:45.000
<v Speaker 1>you reduce that reductase that enzyme, then you have less.

0:40:45.520 --> 0:40:48.560
<v Speaker 2>And Aaron, it goes even further than that, Okay, because

0:40:48.560 --> 0:40:51.880
<v Speaker 2>what happens is that by blocking this enzyme in particular,

0:40:52.120 --> 0:40:54.920
<v Speaker 2>because it is the rate limiting step, meaning it's like

0:40:54.960 --> 0:40:57.399
<v Speaker 2>the slowest one in the daisy chain right when you're

0:40:57.480 --> 0:41:01.960
<v Speaker 2>moving stuff into our house, we dramatically reduce, not just

0:41:02.000 --> 0:41:04.719
<v Speaker 2>like a little bit do we reduce how much cholesterol

0:41:04.760 --> 0:41:07.760
<v Speaker 2>your liver's making. You're dramatically reducing, like putting a huge

0:41:07.760 --> 0:41:11.600
<v Speaker 2>break on how much cholesterol your liver can make. And

0:41:12.120 --> 0:41:17.480
<v Speaker 2>because all of our cells still need cholesterol, our cells

0:41:17.680 --> 0:41:21.440
<v Speaker 2>have to get better at taking cholesterol out of our bloodstream,

0:41:21.680 --> 0:41:25.840
<v Speaker 2>so they actually up regulate those LDL receptors, those velcro,

0:41:25.920 --> 0:41:28.960
<v Speaker 2>sticky hands on the surface of our cells that capture

0:41:29.080 --> 0:41:32.279
<v Speaker 2>our LDL cholesterol floating around in our bloodstream. So it's

0:41:32.320 --> 0:41:35.000
<v Speaker 2>not just that, oh, we're not making as much cholesterol,

0:41:35.040 --> 0:41:37.560
<v Speaker 2>it's that we're not making as much cholesterol and our

0:41:37.600 --> 0:41:41.040
<v Speaker 2>body cells still need cholesterol, so they start vacuuming it

0:41:41.160 --> 0:41:43.200
<v Speaker 2>out of our bloodstream at really high rates.

0:41:44.120 --> 0:41:45.880
<v Speaker 3>Beautiful. Isn't that cool?

0:41:46.200 --> 0:41:46.319
<v Speaker 2>Oh?

0:41:46.400 --> 0:41:47.759
<v Speaker 3>Yeah, I love that.

0:41:48.160 --> 0:41:51.120
<v Speaker 2>There's also some interesting evidence that statin's also might have

0:41:51.239 --> 0:41:54.280
<v Speaker 2>a little bit of like an anti inflammatory effect as well.

0:41:54.680 --> 0:41:56.160
<v Speaker 3>Yeah, and we talked.

0:41:55.840 --> 0:42:00.239
<v Speaker 2>In last week's episode about how important inflammation is in

0:42:00.320 --> 0:42:03.680
<v Speaker 2>the process of atherosclerosis or in the process of that

0:42:03.760 --> 0:42:08.279
<v Speaker 2>cholesterol actually forming a plaque in your bloodstream. Inflammation is

0:42:08.320 --> 0:42:10.479
<v Speaker 2>an integral part of that, and so there's some thought

0:42:10.520 --> 0:42:13.680
<v Speaker 2>that there's also an anti inflammatory effect of statins, though

0:42:13.680 --> 0:42:17.600
<v Speaker 2>we don't fully understand that mechanism there. So that's how

0:42:17.600 --> 0:42:22.480
<v Speaker 2>statins work, and they're incredibly effective erin. There was a

0:42:22.520 --> 0:42:26.880
<v Speaker 2>meta analysis from twenty sixteen that was really interesting, So

0:42:26.880 --> 0:42:29.239
<v Speaker 2>it's kind of old now, but it looked at over

0:42:29.280 --> 0:42:32.000
<v Speaker 2>fifty different studies that looked at all the different possible

0:42:32.000 --> 0:42:35.040
<v Speaker 2>interventions that we had at that time and all of

0:42:35.160 --> 0:42:40.480
<v Speaker 2>the randomized control trials of those different interventions and the

0:42:40.560 --> 0:42:45.000
<v Speaker 2>effect of lowering LDL cholesterol on cardiovascular disease risk by

0:42:45.040 --> 0:42:51.120
<v Speaker 2>these different interventions. Okay, we had twenty five trials on statins,

0:42:52.239 --> 0:42:55.840
<v Speaker 2>twenty five of them compared to only four diet trials

0:42:56.239 --> 0:42:59.640
<v Speaker 2>compared to only two at the time on PCSK nine

0:42:59.680 --> 0:43:01.480
<v Speaker 2>in hibit which I'll get to in a second, right

0:43:01.760 --> 0:43:04.439
<v Speaker 2>one on a zmib, which is another medicine that we use.

0:43:04.800 --> 0:43:07.040
<v Speaker 2>And so what that means is not only do we

0:43:07.120 --> 0:43:10.120
<v Speaker 2>have so much data on their effect, it also means

0:43:10.160 --> 0:43:14.360
<v Speaker 2>that our confidence intervals on just exactly how effective they

0:43:14.400 --> 0:43:18.680
<v Speaker 2>are are really narrow for statins. So we know, like

0:43:18.840 --> 0:43:22.920
<v Speaker 2>without a doubt that statins are extremely effective at lowering

0:43:23.000 --> 0:43:27.320
<v Speaker 2>our LDL cholesterol and at reducing the risk of adverse

0:43:27.360 --> 0:43:28.440
<v Speaker 2>cardiovascular events.

0:43:28.880 --> 0:43:31.279
<v Speaker 3>Period is that what is what did that study show?

0:43:31.360 --> 0:43:33.960
<v Speaker 1>The meta analysis show in terms of like that by

0:43:34.000 --> 0:43:35.520
<v Speaker 1>the numbers impact.

0:43:35.320 --> 0:43:38.520
<v Speaker 2>So by the numbers, statins are the most consistent. Diet

0:43:38.640 --> 0:43:41.799
<v Speaker 2>is A has a slightly less effect but still a

0:43:41.840 --> 0:43:45.200
<v Speaker 2>significant effect. PCSK nines, which I'll get to in a second,

0:43:45.480 --> 0:43:48.799
<v Speaker 2>have the greatest effect. They lower LDL cholesterol the most

0:43:48.920 --> 0:43:51.160
<v Speaker 2>and they reduce your risk the most. But the confidence

0:43:51.200 --> 0:43:53.480
<v Speaker 2>intervals are super wide because at least at that time,

0:43:53.480 --> 0:43:56.759
<v Speaker 2>we just didn't have as much data on them, right, right, Yeah,

0:43:56.760 --> 0:43:58.600
<v Speaker 2>and then the other ones are in between. But statins

0:43:58.600 --> 0:44:01.200
<v Speaker 2>are like like pound I guess, I don't know if

0:44:01.239 --> 0:44:04.040
<v Speaker 2>that's right, but like incredibly effective and like just so

0:44:04.200 --> 0:44:05.719
<v Speaker 2>much good data to support them.

0:44:06.080 --> 0:44:08.839
<v Speaker 1>We're really dialed in on how statins work and how

0:44:08.880 --> 0:44:09.479
<v Speaker 1>well they work.

0:44:09.920 --> 0:44:10.319
<v Speaker 3>Are there?

0:44:10.560 --> 0:44:13.480
<v Speaker 1>What are the differences between different types of statins?

0:44:13.880 --> 0:44:17.120
<v Speaker 2>Great question, So different types of statins. A lot of

0:44:17.120 --> 0:44:20.640
<v Speaker 2>the difference is in their potency. So some statins can

0:44:20.800 --> 0:44:24.279
<v Speaker 2>lower your LDL cholesterol to a much greater degree than

0:44:24.320 --> 0:44:28.520
<v Speaker 2>other statins, the exact of like why, I don't know, okay,

0:44:29.440 --> 0:44:32.160
<v Speaker 2>but that means that we have statins that vary in

0:44:32.239 --> 0:44:36.040
<v Speaker 2>what we call their intensity, And by intensity we mean

0:44:36.160 --> 0:44:41.160
<v Speaker 2>how much, by what percentage are we lowering your LDL cholesterol.

0:44:41.400 --> 0:44:43.160
<v Speaker 2>So if I can give you a medicine that's going

0:44:43.239 --> 0:44:46.560
<v Speaker 2>to lower your LDL cholesterol by at least fifty percent,

0:44:47.360 --> 0:44:51.239
<v Speaker 2>that's considered a high intensity statin regimen. And if it's

0:44:51.239 --> 0:44:53.959
<v Speaker 2>by less than thirty percent, then that's considered a low

0:44:54.040 --> 0:44:59.120
<v Speaker 2>intensity regimen. And then there's intermediate in between. Okay, okay, yeah, moderate.

0:45:00.239 --> 0:45:03.919
<v Speaker 2>There's also differences in like some of them are more lipophilic,

0:45:04.080 --> 0:45:06.600
<v Speaker 2>so they're more like fats, and some of them are

0:45:06.600 --> 0:45:09.880
<v Speaker 2>more hydrophilic, so they're more like They act more like

0:45:09.920 --> 0:45:13.560
<v Speaker 2>proteins in that they're more like soluble in water, and

0:45:13.640 --> 0:45:15.920
<v Speaker 2>so that might differ in how much they build up

0:45:15.920 --> 0:45:18.920
<v Speaker 2>in different tissues in your body. But there's not great

0:45:19.000 --> 0:45:22.160
<v Speaker 2>data that says that one is more or less likely

0:45:22.200 --> 0:45:24.120
<v Speaker 2>to cause side effects than the other. And that's the

0:45:24.120 --> 0:45:26.680
<v Speaker 2>next thing I want to briefly talk about because it's

0:45:26.719 --> 0:45:30.240
<v Speaker 2>an important part of the statin story and you mentioned

0:45:30.239 --> 0:45:33.319
<v Speaker 2>it as well Erin it is not the case that

0:45:33.360 --> 0:45:39.239
<v Speaker 2>side effects don't exist. Any medication, any therapy really has

0:45:39.239 --> 0:45:42.960
<v Speaker 2>the potential to cause side effects. And like you mentioned, Aaron,

0:45:43.160 --> 0:45:47.280
<v Speaker 2>the most cited side effect that causes people to stop

0:45:47.400 --> 0:45:51.440
<v Speaker 2>taking a statin medication is muscle symptoms, and that's a

0:45:51.480 --> 0:45:56.040
<v Speaker 2>really general term. It's often muscle pain or muscle aches,

0:45:56.120 --> 0:46:00.239
<v Speaker 2>or sometimes muscle weakness. Now there's also other things like

0:46:00.239 --> 0:46:04.799
<v Speaker 2>gastro intestinal side effects or liver enzymes can increase, which

0:46:04.840 --> 0:46:08.040
<v Speaker 2>is usually transient and can be completely reversed either by

0:46:08.040 --> 0:46:10.400
<v Speaker 2>going down on the dose or stopping the statin. But

0:46:10.520 --> 0:46:15.040
<v Speaker 2>muscle effects are like the big one, right and there

0:46:15.120 --> 0:46:19.000
<v Speaker 2>was a recent meta analysis that looked at data from

0:46:19.080 --> 0:46:22.360
<v Speaker 2>randomized control trials from over one hundred and fifty thousand

0:46:22.360 --> 0:46:27.600
<v Speaker 2>people and twenty three different studies that were comparing either

0:46:27.880 --> 0:46:31.720
<v Speaker 2>statins versus place EBO or different intensity as a statin,

0:46:31.840 --> 0:46:35.640
<v Speaker 2>so that high intensity versus low intensity therapy. And what

0:46:35.680 --> 0:46:39.400
<v Speaker 2>they found is not that muscle symptoms were never reported

0:46:39.440 --> 0:46:43.920
<v Speaker 2>by any means, but that by comparing all these different regimens,

0:46:44.080 --> 0:46:48.160
<v Speaker 2>what they estimated was that less than ten percent of

0:46:48.239 --> 0:46:52.080
<v Speaker 2>all of the reports of muscle symptoms could actually be

0:46:52.239 --> 0:46:55.239
<v Speaker 2>directly attributed to statins themselves.

0:46:55.520 --> 0:46:57.680
<v Speaker 3>Does that make sense, I think so.

0:46:57.680 --> 0:47:00.680
<v Speaker 1>So the it's not talking about the rate of side

0:47:00.680 --> 0:47:05.320
<v Speaker 1>effects that happen, No, how much of those side effects

0:47:05.360 --> 0:47:09.920
<v Speaker 1>are statin's directly responsible for cause exactly? And is this

0:47:10.080 --> 0:47:12.359
<v Speaker 1>based on like do we understand mechanism?

0:47:12.600 --> 0:47:13.760
<v Speaker 2>Oh, such a good question.

0:47:13.800 --> 0:47:14.240
<v Speaker 1>We don't.

0:47:14.680 --> 0:47:17.920
<v Speaker 2>We don't. Because the vast majority of these, even the

0:47:17.960 --> 0:47:21.840
<v Speaker 2>side effects that could be attributed to statins are considered mild.

0:47:22.200 --> 0:47:25.080
<v Speaker 2>A lot of people actually will continue their statin and

0:47:25.360 --> 0:47:28.160
<v Speaker 2>the amount of people who report symptoms after the first

0:47:28.239 --> 0:47:30.880
<v Speaker 2>year actually goes down. So it's usually in that first

0:47:30.920 --> 0:47:33.839
<v Speaker 2>year of therapy. Realistically, it's usually within the first few

0:47:33.880 --> 0:47:36.719
<v Speaker 2>weeks or months of starting a statin medicine that people

0:47:36.719 --> 0:47:39.280
<v Speaker 2>are more likely to have effects directly related to the statin.

0:47:40.560 --> 0:47:43.400
<v Speaker 2>But no, we don't understand exactly the mechanism. But most

0:47:43.440 --> 0:47:47.200
<v Speaker 2>of them are mild and they do not result in

0:47:47.440 --> 0:47:52.480
<v Speaker 2>actual damage to the muscle, tissue or myopathy. Now that

0:47:52.520 --> 0:47:57.480
<v Speaker 2>does not mean that they can't ever, Right, there are

0:47:57.600 --> 0:48:01.600
<v Speaker 2>more serious events like rhabdomyolysis, and that is estimated to

0:48:01.640 --> 0:48:07.040
<v Speaker 2>occur about four excess cases per ten thousand people if

0:48:07.080 --> 0:48:09.560
<v Speaker 2>you're on a high intensity statin. Does that mean there's

0:48:09.600 --> 0:48:12.120
<v Speaker 2>only four But like some people get rabdo that has

0:48:12.160 --> 0:48:15.080
<v Speaker 2>nothing to do with statins, So statins will call its

0:48:15.200 --> 0:48:18.400
<v Speaker 2>four excess cases for every ten thousand people on a

0:48:18.480 --> 0:48:19.680
<v Speaker 2>high intensity statin.

0:48:19.920 --> 0:48:22.200
<v Speaker 3>Is it more common? Okay you were about to say yes.

0:48:22.400 --> 0:48:24.840
<v Speaker 2>Yeah, and one per ten thousand on less intensive So

0:48:24.880 --> 0:48:28.080
<v Speaker 2>it does go up, like the chances of side effects

0:48:28.120 --> 0:48:30.879
<v Speaker 2>and the chances of more severe side effects go up

0:48:30.920 --> 0:48:35.000
<v Speaker 2>with intensity. So sometimes just going down from a high

0:48:35.080 --> 0:48:38.239
<v Speaker 2>intensity regimen to a lower intensity regimen takes away side

0:48:38.239 --> 0:48:40.480
<v Speaker 2>effects entirely for people, and that's enough and then you're

0:48:40.520 --> 0:48:43.239
<v Speaker 2>still getting some benefit, just maybe not quite as much

0:48:43.280 --> 0:48:45.120
<v Speaker 2>as you were on a high intensity regimen.

0:48:45.560 --> 0:48:49.080
<v Speaker 1>Okay, question about that meta analysis. You said that ten

0:48:49.120 --> 0:48:53.799
<v Speaker 1>percent of the side effects experience are directly attributable to statins.

0:48:54.120 --> 0:48:56.920
<v Speaker 3>What is the ninety percent? Where does that get attributed to?

0:48:57.200 --> 0:48:59.480
<v Speaker 2>I don't know, I don't We don't have an answer

0:48:59.480 --> 0:48:59.759
<v Speaker 2>to that.

0:49:00.320 --> 0:49:01.920
<v Speaker 3>Just the hyper didn't suggest anything.

0:49:02.040 --> 0:49:04.200
<v Speaker 2>No any answers, Okay, no, I mean some of it.

0:49:04.360 --> 0:49:07.120
<v Speaker 2>They're like, is it just aging, is it just no

0:49:07.239 --> 0:49:10.600
<v Speaker 2>stibo effect? Is it like a bunch of different possible things,

0:49:11.320 --> 0:49:12.920
<v Speaker 2>but not like a clear answer. No.

0:49:13.719 --> 0:49:16.080
<v Speaker 1>And so this was like by looking at people who

0:49:16.160 --> 0:49:19.799
<v Speaker 1>are on placebo are still experiencing these side effects and

0:49:19.840 --> 0:49:21.400
<v Speaker 1>we don't know what's causing that, Okay.

0:49:21.239 --> 0:49:24.200
<v Speaker 2>Right, So then you're looking at like how many excess cases,

0:49:24.520 --> 0:49:28.720
<v Speaker 2>how many excess reports will you get? It was estimated

0:49:28.760 --> 0:49:31.920
<v Speaker 2>like eleven reports of muscle pain or weakness per one

0:49:31.960 --> 0:49:36.640
<v Speaker 2>thousand people on statins in that first year were from statins. Okay,

0:49:37.280 --> 0:49:38.680
<v Speaker 2>eleven per one thousand.

0:49:38.800 --> 0:49:40.920
<v Speaker 3>Right, So it's tricky.

0:49:41.000 --> 0:49:44.000
<v Speaker 2>It's really really really tricky because it's not that these

0:49:44.480 --> 0:49:47.960
<v Speaker 2>symptoms are not real, right, And and if you are

0:49:48.080 --> 0:49:51.759
<v Speaker 2>one of those people who has that severe side effect, right,

0:49:51.840 --> 0:49:54.920
<v Speaker 2>one of four per ten thousand. That's a very real

0:49:55.200 --> 0:49:59.040
<v Speaker 2>effect for you. And so it is always a tricky

0:49:59.080 --> 0:50:03.120
<v Speaker 2>thing to balance because when we are talking about treating

0:50:03.280 --> 0:50:07.000
<v Speaker 2>and preventing, especially when we're talking about preventing cardiovascular disease,

0:50:08.040 --> 0:50:12.200
<v Speaker 2>we are talking both about population level reductions and risk,

0:50:12.480 --> 0:50:16.239
<v Speaker 2>and we're also talking about an individual risk benefit calculation,

0:50:16.640 --> 0:50:20.480
<v Speaker 2>right and so, and those are not the same calculations

0:50:20.480 --> 0:50:22.800
<v Speaker 2>on a population scale versus on an individual scale.

0:50:22.960 --> 0:50:24.160
<v Speaker 3>Yeah, and yeah.

0:50:24.200 --> 0:50:27.200
<v Speaker 2>It doesn't help when people's symptoms are completely ignored, or

0:50:27.239 --> 0:50:30.719
<v Speaker 2>when they're told oh, it's absolutely not from this, or

0:50:30.760 --> 0:50:34.120
<v Speaker 2>when they're told from wellness influencers online that this medication

0:50:34.200 --> 0:50:37.759
<v Speaker 2>that they've been on safely for ten years is now

0:50:37.840 --> 0:50:41.120
<v Speaker 2>causing the symptoms that they're having, right yeah, yeah, yeah, yeah,

0:50:41.120 --> 0:50:42.240
<v Speaker 2>which I see all the time.

0:50:42.360 --> 0:50:45.160
<v Speaker 1>I mean I think that what is a real challenge too,

0:50:45.360 --> 0:50:48.279
<v Speaker 1>is like how do you balance saying Okay, these are

0:50:48.320 --> 0:50:50.840
<v Speaker 1>real symptoms, you are experiencing this, this is very real

0:50:51.640 --> 0:50:53.840
<v Speaker 1>is and deciding is this caused by the statina, is

0:50:53.840 --> 0:50:56.360
<v Speaker 1>this not caused by the statin? Are you going to

0:50:56.400 --> 0:50:59.960
<v Speaker 1>be someone who is the point zero zero one percent

0:51:00.360 --> 0:51:02.719
<v Speaker 1>are right? And then it's like what even if these

0:51:03.000 --> 0:51:06.919
<v Speaker 1>side effects are not directly caused by the statin, they're

0:51:06.960 --> 0:51:10.839
<v Speaker 1>still impeding your ability to say, exercise or something like that.

0:51:10.880 --> 0:51:13.200
<v Speaker 1>And so it's like, gona be helpful for your health, right,

0:51:13.840 --> 0:51:16.680
<v Speaker 1>it's a mess. I'm very curious to hear suggestions on

0:51:16.760 --> 0:51:18.480
<v Speaker 1>how out of a question.

0:51:18.680 --> 0:51:20.880
<v Speaker 2>I mean, I don't know, Like I really think that

0:51:20.920 --> 0:51:22.960
<v Speaker 2>what it always has to come down to is a

0:51:23.000 --> 0:51:27.279
<v Speaker 2>good relationship with a physician or provider that you trust, right,

0:51:27.719 --> 0:51:31.439
<v Speaker 2>who knows you, who you know, who can explain these

0:51:31.440 --> 0:51:34.200
<v Speaker 2>things to you. And like, it's why I don't think

0:51:34.239 --> 0:51:36.920
<v Speaker 2>AI can take over for all doctors Aaron. But maybe

0:51:36.920 --> 0:51:37.800
<v Speaker 2>that's my bias.

0:51:37.880 --> 0:51:40.600
<v Speaker 1>Well it's not, but I think it is the way

0:51:40.760 --> 0:51:44.680
<v Speaker 1>that medicine is going, and like the and has been

0:51:44.760 --> 0:51:45.480
<v Speaker 1>trending in.

0:51:45.440 --> 0:51:47.480
<v Speaker 3>The last twenty years, more.

0:51:47.320 --> 0:51:53.000
<v Speaker 1>Expensive, shorter visits, yep, more video visits that don't always

0:51:53.040 --> 0:51:56.919
<v Speaker 1>necessarily feel like you're having a connection with someone, right,

0:51:56.960 --> 0:51:59.160
<v Speaker 1>it all is just standing in the way of forming

0:51:59.160 --> 0:52:00.640
<v Speaker 1>these relationships.

0:52:00.239 --> 0:52:02.600
<v Speaker 2>I know, because they're the most important thing in my

0:52:03.520 --> 0:52:08.680
<v Speaker 2>highly biased opinion. Ah okay, but we have more options too.

0:52:08.840 --> 0:52:11.359
<v Speaker 2>Some people are gonna have side effects from statins or

0:52:11.400 --> 0:52:13.920
<v Speaker 2>they're just like no, I will not take a statin. Cool,

0:52:14.120 --> 0:52:17.120
<v Speaker 2>don't worry. We have other options now, and I'm not

0:52:17.120 --> 0:52:18.640
<v Speaker 2>going to go through every single one, but I'm going

0:52:18.719 --> 0:52:20.799
<v Speaker 2>to call out two that are probably like the two

0:52:20.840 --> 0:52:24.879
<v Speaker 2>biggest groups that we use. One is called zetimibe, and

0:52:25.080 --> 0:52:29.640
<v Speaker 2>this is a drug that blocks a protein that's in

0:52:29.760 --> 0:52:33.000
<v Speaker 2>the cell membranes of our guts and our bile ducts.

0:52:33.320 --> 0:52:36.279
<v Speaker 2>So what this does is it blocks the amount of

0:52:36.360 --> 0:52:40.880
<v Speaker 2>cholesterol that we are absorbing and reabsorbing. So this one,

0:52:40.920 --> 0:52:43.840
<v Speaker 2>it doesn't have as huge of an effect by any means,

0:52:43.840 --> 0:52:47.000
<v Speaker 2>but it can still lower cholesterol, often by like ten percent.

0:52:47.080 --> 0:52:50.479
<v Speaker 2>We're talking LDL cholesterol. It can lower you. So that's

0:52:50.560 --> 0:52:53.399
<v Speaker 2>not nothing to shake a stick at. So now let

0:52:53.480 --> 0:52:56.920
<v Speaker 2>me talk about the one that people are so excited about.

0:52:56.920 --> 0:52:59.920
<v Speaker 2>And then I said multiple times that is a non

0:53:00.080 --> 0:53:04.399
<v Speaker 2>since we're called PCSK nine inhibitor skin. Okay. PCSK nine

0:53:04.520 --> 0:53:06.560
<v Speaker 2>is the shorthand name for a protein that I'm not

0:53:06.560 --> 0:53:08.400
<v Speaker 2>going to tell you the name of because I don't

0:53:08.640 --> 0:53:10.880
<v Speaker 2>know it. It's too long. But this is a protein

0:53:10.920 --> 0:53:15.360
<v Speaker 2>that our liver makes. It's really interesting. Its job this

0:53:15.520 --> 0:53:22.840
<v Speaker 2>protein is to degrade break down LDL receptor proteins. Okay,

0:53:23.560 --> 0:53:26.799
<v Speaker 2>so this protein is kind of like an anti recycler

0:53:27.719 --> 0:53:32.400
<v Speaker 2>of this protein, of this receptor who usually collects the

0:53:32.600 --> 0:53:37.160
<v Speaker 2>LDL in our bloodstream. Okay, yeah, Why does this protein

0:53:37.239 --> 0:53:39.880
<v Speaker 2>do this, I don't know right now, but that is

0:53:39.880 --> 0:53:44.640
<v Speaker 2>what it does. So if you can block this enzyme,

0:53:45.200 --> 0:53:51.560
<v Speaker 2>this protein, then you will have more LDL receptors available

0:53:51.840 --> 0:53:55.720
<v Speaker 2>to be reused and recycled to be collecting our LDL

0:53:55.840 --> 0:53:59.360
<v Speaker 2>cholesterol in our bloodstream.

0:53:59.680 --> 0:54:04.360
<v Speaker 1>So this is like a velcro glove thief, this this protein.

0:54:04.239 --> 0:54:08.160
<v Speaker 2>The protein. Yeah, PCSK nine exactly, it's a velcro glove thief.

0:54:08.480 --> 0:54:12.560
<v Speaker 1>Then the velco gloves are numerous to catch all those

0:54:12.719 --> 0:54:14.720
<v Speaker 1>tennis balls of LDL.

0:54:15.200 --> 0:54:16.600
<v Speaker 2>I really like this analogy, by the.

0:54:16.560 --> 0:54:19.560
<v Speaker 3>Way, it's a really good analogy. I'm yeah, thanks.

0:54:19.600 --> 0:54:21.360
<v Speaker 2>You know, I don't always come up with good ones.

0:54:21.200 --> 0:54:22.960
<v Speaker 1>So I mean the best I get it was Bill Buckner.

0:54:23.040 --> 0:54:24.360
<v Speaker 1>So I've really.

0:54:24.160 --> 0:54:28.800
<v Speaker 2>Enjoyed that so much more than I can say. Yeah,

0:54:28.840 --> 0:54:32.239
<v Speaker 2>So that is how PCSK nine inhibitors work. The main group, Like,

0:54:32.280 --> 0:54:34.200
<v Speaker 2>there's a couple different medicines that we use that are

0:54:34.280 --> 0:54:39.040
<v Speaker 2>mostly monoclonal antibodies. They're really interesting because a lot of times,

0:54:39.040 --> 0:54:40.880
<v Speaker 2>Like they're not a pill that you have to take

0:54:40.920 --> 0:54:44.279
<v Speaker 2>every day. It's like an injectable medicine that you take

0:54:44.280 --> 0:54:46.839
<v Speaker 2>every week or two weeks, depending on the medicine. There's

0:54:46.880 --> 0:54:51.719
<v Speaker 2>also something called in chlyserin, which is a small interfering

0:54:51.920 --> 0:54:59.520
<v Speaker 2>RNA molecule okay, that binds to this protein's PCSK nine's

0:54:59.840 --> 0:55:04.240
<v Speaker 2>m and degrades it. So it's also affecting that same system,

0:55:04.560 --> 0:55:09.040
<v Speaker 2>it's just not blocking the receptor itself. Isn't that so cool?

0:55:09.400 --> 0:55:10.040
<v Speaker 3>Wow?

0:55:10.160 --> 0:55:12.720
<v Speaker 2>And the data on all of these medicines that affect

0:55:12.760 --> 0:55:16.560
<v Speaker 2>PCSK nine it is incredibly strong. So we talked about

0:55:16.600 --> 0:55:19.040
<v Speaker 2>that that meta analysis from ten years ago or so.

0:55:19.360 --> 0:55:26.040
<v Speaker 2>PCSK nine inhibitors reduce your LDL drastically and can drastically

0:55:26.080 --> 0:55:30.359
<v Speaker 2>also reduce cardiovascular events, especially in people who are very

0:55:30.440 --> 0:55:33.400
<v Speaker 2>high risk, meaning people that we are doing secondary prevention

0:55:34.040 --> 0:55:37.439
<v Speaker 2>who already have you know, cardiovascular dues, who have maybe

0:55:37.440 --> 0:55:39.279
<v Speaker 2>already had a heart attack or a stroke and we

0:55:39.440 --> 0:55:41.960
<v Speaker 2>really need to lower that cholesterol, or people who are

0:55:42.000 --> 0:55:46.319
<v Speaker 2>just very high risk. Right, So in those populations is

0:55:46.320 --> 0:55:50.080
<v Speaker 2>mostly where it's been studied, and so cardiologists love this medicine.

0:55:50.800 --> 0:55:55.759
<v Speaker 2>The biggest issues are as with all new drugs, especially

0:55:55.800 --> 0:56:01.080
<v Speaker 2>ones that are fancy things like siRNA and monoclonal antibodies.

0:56:01.120 --> 0:56:05.960
<v Speaker 2>They are expensive as heck, especially in this country. We

0:56:06.040 --> 0:56:09.560
<v Speaker 2>also just don't have nearly as much data on them

0:56:09.600 --> 0:56:12.200
<v Speaker 2>as we do for statins, so the error bars on

0:56:12.239 --> 0:56:16.160
<v Speaker 2>their benefit is still messier, even though they still have

0:56:16.200 --> 0:56:17.040
<v Speaker 2>a really good effect.

0:56:18.000 --> 0:56:20.560
<v Speaker 3>Do we have information about side effects?

0:56:20.960 --> 0:56:22.879
<v Speaker 2>It's a great question. I should have looked into it more.

0:56:22.920 --> 0:56:26.279
<v Speaker 2>There definitely can be side effects, but I honestly just

0:56:26.360 --> 0:56:29.359
<v Speaker 2>did not do a good job of looking into them

0:56:29.400 --> 0:56:32.600
<v Speaker 2>as much. So I will get back to you on that. Okay.

0:56:33.840 --> 0:56:37.640
<v Speaker 1>I'm not to have a question sort of like about lowering.

0:56:37.680 --> 0:56:41.880
<v Speaker 1>So we've talked about lowering and the importance of having

0:56:42.120 --> 0:56:44.880
<v Speaker 1>lower levels, but there is such a thing as too low.

0:56:45.160 --> 0:56:47.000
<v Speaker 3>What are consequences of that?

0:56:47.200 --> 0:56:51.160
<v Speaker 2>That's a great question. I don't have a number for you, Okay.

0:56:51.800 --> 0:56:57.080
<v Speaker 2>What the data shows is that the higher your individual

0:56:57.239 --> 0:57:02.239
<v Speaker 2>risk of cardiovascular disease, right, Because cardiovascular disease is not

0:57:02.520 --> 0:57:03.600
<v Speaker 2>only cholesterol.

0:57:03.680 --> 0:57:05.640
<v Speaker 3>No, no, no, I hope that I.

0:57:05.360 --> 0:57:07.680
<v Speaker 2>Have made that clear. It is not by any means

0:57:07.680 --> 0:57:11.000
<v Speaker 2>only cholesterol, but lower in cholesterol is one of the

0:57:11.040 --> 0:57:13.880
<v Speaker 2>big ways that we have to reduce the chances that

0:57:13.920 --> 0:57:16.880
<v Speaker 2>you're going to develop or have really bad outcomes like

0:57:16.880 --> 0:57:19.960
<v Speaker 2>a heart attack or a stroke or death from cardiovascular disease.

0:57:21.000 --> 0:57:24.720
<v Speaker 2>And so what we know is that the higher your

0:57:24.760 --> 0:57:27.200
<v Speaker 2>individual risk based on all of your other risk factors,

0:57:27.240 --> 0:57:29.320
<v Speaker 2>age whether or not you smoke, how much alcohol you drink,

0:57:29.360 --> 0:57:31.760
<v Speaker 2>your BMI, your blood pressure, whether you're on a blood

0:57:31.760 --> 0:57:35.440
<v Speaker 2>pressure medicine, your kidney function, based on all of those things,

0:57:35.840 --> 0:57:39.520
<v Speaker 2>the higher your risk, the lower we need to push

0:57:39.560 --> 0:57:43.680
<v Speaker 2>your cholesterol to really lower your risk of bad outcomes.

0:57:44.760 --> 0:57:47.520
<v Speaker 2>So people who are very high risk, in the newest guidelines,

0:57:47.880 --> 0:57:50.160
<v Speaker 2>people who are very high risk, the recommendation is to

0:57:50.200 --> 0:57:54.120
<v Speaker 2>reduce their LDL to less than fifty five. And that's

0:57:54.320 --> 0:57:57.320
<v Speaker 2>very low, and we haven't seen any bad outcomes from that,

0:57:57.480 --> 0:57:59.960
<v Speaker 2>meaning we haven't found a number that is too low

0:58:00.880 --> 0:58:04.080
<v Speaker 2>for those people who are very high risk, okay, but

0:58:04.240 --> 0:58:07.760
<v Speaker 2>for other people, we haven't necessarily shown that there is

0:58:07.920 --> 0:58:11.960
<v Speaker 2>a benefit to pushing them that low. And so for

0:58:12.040 --> 0:58:14.360
<v Speaker 2>most other people, the recommendation is going to be either

0:58:14.720 --> 0:58:17.880
<v Speaker 2>less than seventy or less than one hundred, depending again

0:58:17.960 --> 0:58:21.480
<v Speaker 2>on what your risk is of cardiovascular disease development.

0:58:21.880 --> 0:58:26.120
<v Speaker 1>Huh, yeah, So prolonged use of statins are like long

0:58:26.160 --> 0:58:27.160
<v Speaker 1>time use of statins.

0:58:27.160 --> 0:58:30.240
<v Speaker 3>Basically, if your blood cholesterol.

0:58:29.720 --> 0:58:31.000
<v Speaker 1>Is high enough that you need to be on a

0:58:31.040 --> 0:58:33.000
<v Speaker 1>statin or you are prescribed as statin.

0:58:33.280 --> 0:58:35.960
<v Speaker 2>Or another lipid lowering medicine or something like that, you

0:58:36.040 --> 0:58:39.439
<v Speaker 2>are on that regimen for the rest of your life.

0:58:40.000 --> 0:58:45.520
<v Speaker 2>Often yeah, often, yeah, that because again that's the data

0:58:45.520 --> 0:58:47.920
<v Speaker 2>that we have, right right, And we'll talk in a

0:58:47.960 --> 0:58:52.960
<v Speaker 2>second about how much atherosclerosis is. It is a disease

0:58:53.000 --> 0:58:57.800
<v Speaker 2>of long term right, Yeah, it's not a short term.

0:58:57.840 --> 0:58:59.760
<v Speaker 2>It's not the rabbits that just get it in a

0:58:59.800 --> 0:59:03.320
<v Speaker 2>week or two. It is a long term disease kind

0:59:03.320 --> 0:59:05.560
<v Speaker 2>of thing, and so that is why it requires long

0:59:05.640 --> 0:59:06.320
<v Speaker 2>term management.

0:59:06.560 --> 0:59:10.600
<v Speaker 1>Plaques weren't built in a just like rome wasn't built

0:59:10.640 --> 0:59:11.400
<v Speaker 1>in a thing exactly.

0:59:11.480 --> 0:59:13.760
<v Speaker 2>Whatever, Yeah, isn't it a day?

0:59:14.880 --> 0:59:17.840
<v Speaker 1>Probably I'm terrible with like saying so I thought I

0:59:17.880 --> 0:59:18.919
<v Speaker 1>cannot remember them.

0:59:19.120 --> 0:59:20.840
<v Speaker 3>I mix my metaphors constantly.

0:59:21.120 --> 0:59:26.200
<v Speaker 2>I love it. I want to just briefly like, shout

0:59:26.240 --> 0:59:30.479
<v Speaker 2>out is not the right word upon rage about rage

0:59:30.640 --> 0:59:33.240
<v Speaker 2>or how sure because there is a lot out there

0:59:33.320 --> 0:59:37.040
<v Speaker 2>right now on like, oh, alternative types of medicines to

0:59:37.520 --> 0:59:42.240
<v Speaker 2>lower cholesterol. And I'm not talking about lifestyle interventions like

0:59:42.320 --> 0:59:44.560
<v Speaker 2>diet and exercise changes. We already talked about those. They

0:59:44.560 --> 0:59:48.160
<v Speaker 2>have decent evidence they're an important part of this. But

0:59:48.480 --> 0:59:51.480
<v Speaker 2>one of the things that some people use or claim

0:59:51.720 --> 0:59:55.880
<v Speaker 2>to have a benefit in lowering cholesterol are phytosols, right.

0:59:55.960 --> 0:59:59.919
<v Speaker 2>Those are plant based cholesterols, and it is possible, based

0:59:59.920 --> 1:00:04.560
<v Speaker 2>on on some like observational data, that consuming high levels

1:00:04.600 --> 1:00:08.760
<v Speaker 2>of these plant based cholesterols or plant based sterols might

1:00:08.960 --> 1:00:12.280
<v Speaker 2>decrease LDL cholesterol, especially when you look at people on

1:00:12.320 --> 1:00:15.800
<v Speaker 2>like vegan diets who have quite a lot of phytosterol

1:00:15.800 --> 1:00:20.600
<v Speaker 2>consumption or who are taking other additives of phytosterols. But

1:00:21.240 --> 1:00:25.160
<v Speaker 2>we have no randomized control trial data on these, and

1:00:25.320 --> 1:00:28.040
<v Speaker 2>the data that do exist, what's really interesting is that

1:00:28.200 --> 1:00:31.920
<v Speaker 2>they seem to be most effective when they're consumed with meals,

1:00:32.080 --> 1:00:35.400
<v Speaker 2>meaning when you're getting it from foods rather than just

1:00:35.720 --> 1:00:40.360
<v Speaker 2>a supplement or an addition. And of course, as we

1:00:40.400 --> 1:00:42.520
<v Speaker 2>talk about so often on this podcast, Aaron, there are

1:00:42.560 --> 1:00:47.720
<v Speaker 2>no regulations on supplements, whether we're talking about phytosterols or

1:00:48.360 --> 1:00:53.080
<v Speaker 2>other nutraceuticals. And one of the big ones out there

1:00:53.280 --> 1:00:56.439
<v Speaker 2>for cholesterol is red yea's rice. You mentioned it erin.

1:00:58.000 --> 1:01:04.040
<v Speaker 2>The mechanism of the compound produced by this yeast that's

1:01:04.080 --> 1:01:09.560
<v Speaker 2>grown on rice is that it blocks hmg CoA reductastes.

1:01:09.800 --> 1:01:11.640
<v Speaker 3>It's a statin. It's a statin.

1:01:11.840 --> 1:01:14.560
<v Speaker 1>But okay, because it's coming from a plan, it's extracted

1:01:14.560 --> 1:01:17.480
<v Speaker 1>from a plant. Plants produce different levels of these things,

1:01:17.520 --> 1:01:20.000
<v Speaker 1>and so you have no idea how much you're getting,

1:01:20.360 --> 1:01:22.880
<v Speaker 1>and so it can be dangerous. You could be on

1:01:23.440 --> 1:01:28.240
<v Speaker 1>very low dose, non existent dose versus high intensity or whatever.

1:01:28.520 --> 1:01:31.000
<v Speaker 2>And most brands in studies that have looked at this

1:01:31.160 --> 1:01:36.840
<v Speaker 2>have no detectable levels of that actual compound. Right, There's

1:01:36.880 --> 1:01:40.959
<v Speaker 2>no regulation on the composition of those particular supplements. There's

1:01:41.000 --> 1:01:43.760
<v Speaker 2>no regulation on how much of that compound, like you said,

1:01:43.800 --> 1:01:45.960
<v Speaker 2>the yeast is actually going to produce when it's fermented.

1:01:46.000 --> 1:01:49.000
<v Speaker 2>So there's batch to batch variation, there's brand to brand variation,

1:01:49.160 --> 1:01:51.920
<v Speaker 2>and at the end of the day, it's an unregulated statin.

1:01:52.840 --> 1:01:54.000
<v Speaker 3>It's unregulated.

1:01:55.000 --> 1:01:58.280
<v Speaker 2>Yeah, And I don't want to make that sound like, oh, well,

1:01:58.280 --> 1:02:03.560
<v Speaker 2>pharmaceutical companies are just the best thing ever, Right, they're not.

1:02:03.880 --> 1:02:06.080
<v Speaker 2>And it's also not the case that our guidelines might

1:02:06.120 --> 1:02:09.520
<v Speaker 2>not be subject to some degree of bias because, like

1:02:09.560 --> 1:02:13.680
<v Speaker 2>you mentioned, of the conflicts of interests that exist within

1:02:14.080 --> 1:02:18.560
<v Speaker 2>cardiology and within like I mean, all fields of medicine. Realistically,

1:02:19.400 --> 1:02:22.040
<v Speaker 2>a good number of the authors and the people who

1:02:22.040 --> 1:02:24.520
<v Speaker 2>were involved in the peer review process for the newest

1:02:24.640 --> 1:02:28.360
<v Speaker 2>DISSIPIDYMA guidelines in the US have financial conflicts of interest

1:02:28.680 --> 1:02:31.360
<v Speaker 2>not just with pharmaceutical companies, but with imaging companies, with

1:02:31.400 --> 1:02:34.920
<v Speaker 2>genetic testing companies. And that doesn't mean that all of

1:02:34.960 --> 1:02:37.800
<v Speaker 2>our data that we have that is so strong isn't

1:02:38.000 --> 1:02:41.960
<v Speaker 2>real or isn't strong, but it just muddies these waters

1:02:42.000 --> 1:02:45.520
<v Speaker 2>even more and it creates this gap where people can

1:02:45.520 --> 1:02:50.960
<v Speaker 2>really exploit that uncertainty totally. And it's really really a

1:02:50.960 --> 1:02:56.280
<v Speaker 2>bummer because atherosclerotic heart disease, including heart attack and stroke,

1:02:56.480 --> 1:03:02.439
<v Speaker 2>kills an estimated nineteen million people worldwide every year. As

1:03:02.480 --> 1:03:05.960
<v Speaker 2>of the twenty twenty three Global Burden of Diseases study. Wow, Yeah,

1:03:06.200 --> 1:03:10.880
<v Speaker 2>an estimated six hundred million people are living with cardiovascular

1:03:10.880 --> 1:03:17.080
<v Speaker 2>disease right now every across the globe. Cardiovascular disease is

1:03:17.160 --> 1:03:20.920
<v Speaker 2>the leading cause of disability just in life years. In

1:03:20.960 --> 1:03:24.840
<v Speaker 2>some countries it is a third to forty to forty

1:03:24.920 --> 1:03:29.680
<v Speaker 2>five percent of all deaths, and of course, especially in

1:03:29.720 --> 1:03:32.840
<v Speaker 2>this country, the estimated costs to healthcare are in the

1:03:33.000 --> 1:03:38.960
<v Speaker 2>hundreds of billions of dollars and an estimated eighty percent

1:03:39.160 --> 1:03:44.640
<v Speaker 2>of this disease is due to modifiable risk factors and cholesterol.

1:03:44.720 --> 1:03:50.000
<v Speaker 2>This relationship between LDL cholesterol and cardiovascular disease is so

1:03:50.360 --> 1:03:54.520
<v Speaker 2>incredibly clear, and it is something that we really have

1:03:54.600 --> 1:04:01.680
<v Speaker 2>the potential to treat right. So it's uh, it's such

1:04:01.720 --> 1:04:05.520
<v Speaker 2>a huge bummer that there are so many people who

1:04:05.560 --> 1:04:09.920
<v Speaker 2>do not have access to this right. And it's not

1:04:10.400 --> 1:04:14.240
<v Speaker 2>just older adults. I think that we think of cardiovascular

1:04:14.280 --> 1:04:18.200
<v Speaker 2>disease as something that only happens to older people. But

1:04:18.680 --> 1:04:21.680
<v Speaker 2>the more that we look at and study the like

1:04:22.520 --> 1:04:27.440
<v Speaker 2>pathogenesis of cardiovascular disease, the more we understand that especially

1:04:27.960 --> 1:04:32.520
<v Speaker 2>cholesterol is a long term exposure that increases your risk.

1:04:33.480 --> 1:04:37.440
<v Speaker 2>So having exposure to higher levels greater than one hundred

1:04:37.760 --> 1:04:41.520
<v Speaker 2>of LDL cholesterol, especially greater than one sixty younger in

1:04:41.600 --> 1:04:46.200
<v Speaker 2>life and for longer periods, increases your risk more than

1:04:46.200 --> 1:04:48.840
<v Speaker 2>if it just goes up over time. If that makes sense, Yes,

1:04:48.880 --> 1:04:51.920
<v Speaker 2>it does make sense. And it's estimated that twelve to

1:04:51.960 --> 1:04:55.480
<v Speaker 2>thirteen percent of young adults have dyslipidemia in this country.

1:04:55.840 --> 1:04:56.120
<v Speaker 1>Wow.

1:04:56.120 --> 1:05:00.160
<v Speaker 2>So that's not a small number, right. It's estimated that

1:05:00.280 --> 1:05:03.520
<v Speaker 2>in the US, if everyone, based on guidelines, who was

1:05:03.560 --> 1:05:07.080
<v Speaker 2>recommended to be on medicine to lower their cholesterol was

1:05:07.160 --> 1:05:10.760
<v Speaker 2>actually on a medicine for this, like a statin, we

1:05:10.840 --> 1:05:16.160
<v Speaker 2>could prevent one million cardiovascular disease events like heart attack, stroke,

1:05:16.200 --> 1:05:20.520
<v Speaker 2>and death in ten years. A million. Whoa Okay, And

1:05:21.720 --> 1:05:24.400
<v Speaker 2>that's just in the US, where we have much better access.

1:05:24.440 --> 1:05:26.959
<v Speaker 2>In low and middle income countries, it's estimated that only

1:05:27.000 --> 1:05:30.560
<v Speaker 2>one in ten people who would be recommended to be

1:05:30.680 --> 1:05:33.120
<v Speaker 2>on some kind of medicine to lower their cholesterol or

1:05:33.160 --> 1:05:37.080
<v Speaker 2>actually on a medicine because they don't have access. Right.

1:05:38.200 --> 1:05:38.960
<v Speaker 2>So that's a lot.

1:05:39.760 --> 1:05:41.360
<v Speaker 3>It's a lot, Eric, It's a.

1:05:41.320 --> 1:05:45.640
<v Speaker 2>Lot, but there is. I just think it's one of

1:05:45.680 --> 1:05:52.480
<v Speaker 2>those situations where medicine has come so far, right, and

1:05:52.560 --> 1:05:57.480
<v Speaker 2>the data that we have is so strong, but it's

1:05:57.520 --> 1:06:00.959
<v Speaker 2>also not all just one thing, and I think that

1:06:00.960 --> 1:06:04.439
<v Speaker 2>that is where some of the kind of confusion and

1:06:05.800 --> 1:06:09.000
<v Speaker 2>uncertainty and doubt can come from. Right, Because we look

1:06:09.040 --> 1:06:12.520
<v Speaker 2>at cardiovascular disease events over time, they're still going up, right,

1:06:12.800 --> 1:06:15.560
<v Speaker 2>But we have these great medicines, but they're still going up.

1:06:16.640 --> 1:06:18.600
<v Speaker 2>And that's because it is so many other things that

1:06:18.640 --> 1:06:20.440
<v Speaker 2>play into it. So this was not an episode just

1:06:20.520 --> 1:06:25.760
<v Speaker 2>only about cardiovascular disease, but cholesterol overall. And that is

1:06:25.800 --> 1:06:26.840
<v Speaker 2>what I have to say Erin.

1:06:28.320 --> 1:06:32.480
<v Speaker 1>It is really complicated and it's so recent, and I

1:06:32.520 --> 1:06:35.960
<v Speaker 1>think that's what contributes a lot to this. And it

1:06:36.000 --> 1:06:38.640
<v Speaker 1>does go to show that you can have the data,

1:06:38.800 --> 1:06:42.800
<v Speaker 1>you can have the treatments, you can have the like

1:06:42.840 --> 1:06:47.480
<v Speaker 1>all of these different facets of in support of this,

1:06:48.160 --> 1:06:51.600
<v Speaker 1>and that's not enough. And so figuring out that gap

1:06:51.760 --> 1:06:54.360
<v Speaker 1>what will make what will be enough? How do we

1:06:55.120 --> 1:06:57.400
<v Speaker 1>actually either get the treatment to people who need it,

1:06:57.640 --> 1:07:00.160
<v Speaker 1>how do we actually develop better treatments.

1:07:00.160 --> 1:07:00.960
<v Speaker 3>Whatever it is?

1:07:01.320 --> 1:07:01.600
<v Speaker 2>Right?

1:07:01.680 --> 1:07:05.000
<v Speaker 1>How do we address those gaps where we're clearly failing.

1:07:05.360 --> 1:07:08.720
<v Speaker 2>Yeah, yeah, it's a great Questionnaaring.

1:07:08.320 --> 1:07:09.600
<v Speaker 3>Hopefully someone figures it out.

1:07:10.040 --> 1:07:14.040
<v Speaker 2>Yeah. Do you want to read so many papers about

1:07:14.320 --> 1:07:17.520
<v Speaker 2>how we got all of this information? We can tell you.

1:07:17.760 --> 1:07:18.440
<v Speaker 2>We can tell you.

1:07:19.160 --> 1:07:22.360
<v Speaker 1>I also want to shout out real quick too, that

1:07:22.800 --> 1:07:27.200
<v Speaker 1>they're speaking like on the subject of misinformation and social media,

1:07:27.360 --> 1:07:32.280
<v Speaker 1>wellness influencers, health influencers, stuff like that. There is Next

1:07:32.320 --> 1:07:36.560
<v Speaker 1>week's book Club episode is an interview with Deborah Cohen.

1:07:37.040 --> 1:07:40.360
<v Speaker 1>It's a book called Bad Influence, and it's really a

1:07:40.360 --> 1:07:41.480
<v Speaker 1>fascinating conversation.

1:07:41.680 --> 1:07:42.800
<v Speaker 3>Definitely tune in.

1:07:42.880 --> 1:07:45.240
<v Speaker 1>There's a whole we have a little bit about Statin's

1:07:45.240 --> 1:07:48.840
<v Speaker 1>in there, so check it out. Yeah, but papers for

1:07:48.920 --> 1:07:52.160
<v Speaker 1>this episode, Okay, I have a bunch more again. I'll

1:07:52.160 --> 1:07:54.880
<v Speaker 1>shout out again that Steinberg series from two thousand and

1:07:54.920 --> 1:07:59.120
<v Speaker 1>four in Interpretive History of the cholesterol controversy, then by

1:07:59.360 --> 1:08:03.880
<v Speaker 1>jew at All from twenty eighteen patient beliefs and attitudes

1:08:03.920 --> 1:08:07.360
<v Speaker 1>just taking statins, and then by Endo a gift from

1:08:07.440 --> 1:08:09.800
<v Speaker 1>nature the birth statins. So that's the person who.

1:08:09.880 --> 1:08:12.320
<v Speaker 2>Oh I love it. Let me tell you where you

1:08:12.360 --> 1:08:15.240
<v Speaker 2>can learn more. I really liked a paper by Silverman

1:08:15.360 --> 1:08:20.560
<v Speaker 2>at All from JAMA twenty sixteen that was the association

1:08:20.640 --> 1:08:24.320
<v Speaker 2>between lowering LDLC which is LDL cholesterol and cardiovascular risk

1:08:24.439 --> 1:08:27.960
<v Speaker 2>reduction among different therapeutic interventions, A systematic review and men analysis.

1:08:28.000 --> 1:08:30.439
<v Speaker 2>That's the one that has really great graphs, honestly on

1:08:30.600 --> 1:08:34.320
<v Speaker 2>like with therabars and the risk reduction. Loved it. I

1:08:34.360 --> 1:08:36.920
<v Speaker 2>have links to the newest guidelines as well too. The

1:08:36.960 --> 1:08:40.880
<v Speaker 2>study looking at the overall risk of cardiovascular disease and

1:08:40.920 --> 1:08:44.800
<v Speaker 2>heart attack was from the Journal of American College of

1:08:44.840 --> 1:08:47.040
<v Speaker 2>Cardiology from twenty twenty three, and that was one of

1:08:47.080 --> 1:08:50.040
<v Speaker 2>the global Burden of Disease studies, so we have that one.

1:08:50.400 --> 1:08:53.200
<v Speaker 2>There's also that twenty twenty two paper by wreath at

1:08:53.240 --> 1:08:55.439
<v Speaker 2>All in the Lancet that was the effect of Statin

1:08:55.479 --> 1:08:58.719
<v Speaker 2>therapy on muscle symptoms and individual participant data meta analysis

1:08:58.760 --> 1:09:02.400
<v Speaker 2>of large scale, randomized double blind trials. But honestly, there's

1:09:02.439 --> 1:09:06.320
<v Speaker 2>so much more there, Aaron, so you everyone can check

1:09:06.360 --> 1:09:08.400
<v Speaker 2>it out on our website this pocastikadi dot com under

1:09:08.479 --> 1:09:09.240
<v Speaker 2>the episode stap.

1:09:10.000 --> 1:09:12.559
<v Speaker 1>Thank you to Bloodmobile for providing the music for this

1:09:12.640 --> 1:09:14.360
<v Speaker 1>episode into all of our episodes.

1:09:14.880 --> 1:09:18.360
<v Speaker 2>Thank you to Leanna and Tom and Mark and Jessica

1:09:18.439 --> 1:09:20.880
<v Speaker 2>and everyone at exactly Right for everything that you do

1:09:20.920 --> 1:09:22.200
<v Speaker 2>to make this podcast possible.

1:09:22.320 --> 1:09:27.960
<v Speaker 1>Thank you, thank you, and thank you to you listeners, subscribers, watchers,

1:09:28.000 --> 1:09:32.040
<v Speaker 1>et cetera. We appreciate you engaging with this podcast so much.

1:09:32.080 --> 1:09:33.720
<v Speaker 1>I know it sounds so clinical when I say that,

1:09:33.760 --> 1:09:37.240
<v Speaker 1>but what I mean is, like anyone who like follows

1:09:37.280 --> 1:09:39.480
<v Speaker 1>us on social media, yeah, whatever.

1:09:39.400 --> 1:09:41.479
<v Speaker 3>Anyway it is, it truly means everything.

1:09:41.840 --> 1:09:45.000
<v Speaker 2>Thank you, thank you, and thank you as always to

1:09:45.080 --> 1:09:47.120
<v Speaker 2>our patrons for your support over on Patreon.

1:09:47.439 --> 1:09:48.760
<v Speaker 3>It means like it.

1:09:49.520 --> 1:09:52.240
<v Speaker 2>I can't believe that you're supporting us there. Thank you. Yeah,

1:09:52.280 --> 1:09:53.160
<v Speaker 2>it really means a lot.

1:09:53.720 --> 1:09:56.160
<v Speaker 3>Until next time, wash your hands.

1:09:55.920 --> 1:09:56.919
<v Speaker 2>You feel the animals.

1:10:01.600 --> 1:10:17.200
<v Speaker 1>Oh Buba buba bumbo ombu